Title,Authors,Platform,Cited_url,Cited_count,Year
Clinical aspects of immunology.,"PGH Gell, RRA Coombs",Clinical Aspects of Immunology.,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7981071552582942304,832049549591953157,13014839303964352686,9505723264134120690",1656,1963
"CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.","A Davies, DL Simmons, G Hale, RA Harrison, H Tighe, PJ Lachmann, ...","Journal of Experimental Medicine 170 (3), 637-654",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=804762075077298278,651,1989
"Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.","S Meri, BP Morgan, A Davies, RH Daniels, MG Olavesen, H Waldmann, ...","Immunology 71 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8085611221452728499,569,1990
"Systemic lupus erythematosus, complement deficiency, and apoptosis","MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport","Advances in immunology 76, 226-324",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4738779868367252754,492,2000
Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well …,"GD Ross, JA Cain, PJ Lachmann","The Journal of Immunology 134 (5), 3307-3315",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1687572354372666888,482,1985
Complement technology,"PJ Lachmann, MJ Hobart, WP Aston","Handbook of experimental immunology 1, 5.1-5.17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8592566520720377711,423,1978
AIDS—an immunologic reevaluation,"M Seligmann, L Chess, JL Fahey, AS Fauci, PJ Lachmann, J L'Age-Stehr, ...","New England Journal of Medicine 311 (20), 1286-1292",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13006795209716844910,364,1984
The localization of in vivo bound complement in tissue sections,"PJ Lachmann, HJ Müller-Eberhard, HG Kunkel, F Paronetto","Journal of Experimental Medicine 115 (1), 63-82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8677112279964882197,320,1962
The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen‐and antigen‐stimulated human peripheral …,"SM McHugh, IR Rifkin, J Deighton, AB Wilson, PJ Lachmann, ...","Clinical & Experimental Immunology 99 (2), 160-167",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15454681888997667669,319,1995
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.,"MG Wing, T Moreau, J Greenwood, RM Smith, G Hale, J Isaacs, ...","The Journal of clinical investigation 98 (12), 2819-2826",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17267977533814142764,299,1996
Reactive lysis: the complement-mediated lysis of unsensitized cells: II. The characterization of activated reactor as C56 and the participation of C8 and C9,"PJ Lachmann, RA Thompson","Journal of Experimental Medicine 131 (4), 643-657",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15314475283354302435,297,1970
"Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and …","GD Ross, WJ Yount, MJ Walport, JB Winfield, CJ Parker, CR Fuller, ...","The Journal of Immunology 135 (3), 2005-2014",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4856334532167101418,286,1985
Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.,"Y Takeuchi, FL Cosset, PJ Lachmann, H Okada, RA Weiss, MK Collins","Journal of Virology 68 (12), 8001-8007",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18278839910997274172,279,1994
Specificity of membrane complement receptor type three (CR3) for ß-glucans,"GD Ross, JA Cain, BL Myones, SL Newman, PJ Lachmann","Complement 4, 61-74",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6761723941516911230,264,1987
The demonstration in human serum of “conglutinogen-activating factor” and its effect on the third component of complement,"PJ Lachmann, HJ Müller-Eberhard","The Journal of Immunology 100 (4), 691-698",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12511623681178632243,245,1968
Bee venom immunotherapy induces a shift in cytokine responses from a TH‐2 to a TH‐1 dominant pattern: comparison of rush and conventional immunotherapy,"SM McHugh, J Deighton, AG Stewart, PJ Lachmann, PW Ewan","Clinical & Experimental Allergy 25 (9), 828-838",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6427404683214763658,218,1995
Reactive lysis: the complement-mediated lysis of unsensitized cells: I. The characterization of the indicator factor and its identification as C7,"RA Thompson, PJ Lachmann","Journal of Experimental Medicine 131 (4), 629-641",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8005727838497209311,217,1970
"Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.","PJ Lachmann, MK Pangburn, RG Oldroyd","Journal of Experimental Medicine 156 (1), 205-216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16840599878527682255,216,1982
The control of homologous lysis,PJ Lachmann,"Immunology today 12 (9), 312-315",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13546957431847446800,213,1991
"Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues.","S Meri, H Waldmann, PJ Lachmann",Laboratory investigation; a journal of technical methods and pathology 65 (5 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16521929449425562386,206,1991
Deficiency of C3 inactivator in man,"N Abramson, CA Alper, PJ Lachmann, FS Rosen, JH Jandl","The Journal of Immunology 107 (1), 19-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14692683322994544155,205,1971
Conglutinin and immunoconglutinins,PJ Lachmann,"Advances in immunology 6, 479-527",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16412858415292715999,205,1967
The effect of antibody isotype and antigenic epitope density on the complement‐fixing activity of immune complexes: a systematic study using chimaeric anti‐NIP antibodies with …,"YML Valim, PJ Lachmann","Clinical & Experimental Immunology 84 (1), 1-8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2972089317758752654,204,1991
The physiological breakdown of the third component of human complement,"RA Harrison, PJ Lachmann","Molecular immunology 17 (1), 9-20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7897023203965939875,199,1980
The alternate pathway of complement activation: the role of C3 and its inactivator (KAF),"PAE Nicol, PJ Lachmann","Immunology 24 (2), 259",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3314716345973825566,199,1973
"Structure of a soluble, glycosylated form of the human complement regulatory protein CD59","CM Fletcher, RA Harrison, PJ Lachmann, D Neuhaus","Structure 2 (3), 185-199",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5384134506205574259,191,1994
Initiation of complement activation,"PJ Lachmann, NC Hughes-Jones","Springer seminars in immunopathology 7 (2-3), 143-162",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18146362118106377854,176,1984
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia,"JA Charlesworth, DG Williams, E Sherington, PJ Lachmann, DK Peters","The Journal of clinical investigation 53 (6), 1578-1587",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14775361528634925041,169,1974
Membrane defence against complement lysis: the structure and biological properties of CD59,"A Davies, PJ Lachmann","Immunologic research 12 (3), 258",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4851557908229175533,168,1993
"Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.","MJ Walport, GD Ross, C Mackworth-Young, JV Watson, N Hogg, ...","Clinical and experimental immunology 59 (3), 547",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4562541076681686397,164,1985
The amplification loop of the complement pathways,PJ Lachmann,"Advances in immunology 104, 115-149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2239834343869567020,160,2009
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.,"PJ Lachmann, L Halbwachs","Clinical and experimental immunology 21 (1), 109",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7680587051987214738,153,1975
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation,"A Martin, PJ Lachmann, L Halbwachs, MJ Hobart","Immunochemistry 13 (4), 317-324",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12381352662033366551,143,1976
Identification of Ss protein as murine C4,"PJ Lachmann, D Grennan, A Martin, P Demant","Nature 258 (5532), 242-243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3912797848735789720,133,1975
Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes,"BA Fernie‐King, DJ Seilly, C Willers, R Würzner, A Davies, PJ Lachmann","Immunology 103 (3), 390-398",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3634212763494170920,132,2001
Inactivator of the third component of complement as an inhibitor in the properdin pathway,"CA Alper, FS Rosen, PJ Lachmann","Proceedings of the National Academy of Sciences 69 (10), 2910-2913",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=378574254704402242,132,1972
Complement technology,"RA Harrison, PJ Lachmann","Handbook of experimental immunology 1, 39.1-39.49",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10923980145775538093,131,1986
Complement studies in membranoproliferative glomerulonephritis,"DK Peters, A Martin, A Weinstein, JS Cameron, TM Barratt, CS Ogg, ...","Clinical and experimental immunology 11 (3), 311",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10135672158119253904,131,1972
Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)‐prone NZB/NZW mice by a new radial enzyme diffusion assay,"M Macanovic, PJ Lachmann","Clinical & Experimental Immunology 108 (2), 220-226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6934213468482049221,130,1997
The treatment of systemic lupus erythematosus (SLE) in NZB/W F,"M Macanovic, D Sinicropi, S Shak, S Baughman, S Thiru, PJ Lachmann","Clinical & Experimental Immunology 106 (2), 243-252",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15725974648592287185,128,1996
Identification of an anti‐monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR,"N Hogg, GD Ross, DB Jones, M Slusarenko, MJ Walport, PJ Lachmann","European journal of immunology 14 (3), 236-243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13763925689813644647,128,1984
Reaction mechanism of the alternative pathway of complement fixation,"PJ Lachmann, P Nicol","The Lancet 301 (7801), 465-467",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=514745543052786516,124,1973
Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme,"BA Fernie-King, DJ Seilly, A Davies, PJ Lachmann","Infection and immunity 70 (9), 4908-4916",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2817603884801960015,119,2002
Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis,"DB Budzko, PJ Lachmann, I McConnell","Cellular immunology 22 (1), 98-109",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2409683923507159192,119,1976
Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells: a possible initiating event in atherosclerotic lesion formation,"J Torzewski, R Oldroyd, P Lachmann, C Fitzsimmons, D Proudfoot, ...","Arteriosclerosis, thrombosis, and vascular biology 16 (5), 673-677",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18131602757120700953,118,1996
Allotypes of complement components in man,"MJ Hobart, PJ Lachmann","Immunological Reviews 32 (1), 26-42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2396254711098752851,117,1976
"Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d, g (alpha 2D), and C3g.","AE Davis, RA Harrison, PJ Lachmann","The Journal of Immunology 132 (4), 1960-1966",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16134663656036590552,113,1984
"The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C [unk] 567 …","PJ Lachmann, AB Kay, RA Thompson","Immunology 19 (6), 895",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6152397678122524536,113,1970
Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related …,"GD Ross, RA Thompson, MJ Walport, TA Springer, JV Watson, RH Ward, ...","Blood 66 (4), 882-890",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10986062909981635603,112,1985
Polymorphism of human C5,"MJ Hobart, MAV Guedes, PJ Lachmann","Annals of human genetics 45 (1), 1-4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10108684638407690544,112,1981
Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum,"M Sussman, JH Jones, JD Almeida, PJ Lachmann","Clinical and experimental immunology 14 (4), 531",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11890537907975168712,111,1973
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics,"PS Hiemstra, BA Fernie-King, J McMichael, PJ Lachmann, JM Sallenave","Current pharmaceutical design 10 (23), 2891-2905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7097897410936642607,110,2004
Measles virus receptor on human T lymphocytes,"H Valdimarsson, G Agnarsdottir, PJ Lachmann","Nature 255 (5509), 554",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6441294632645629584,110,1975
Complement-mediated adipocyte lysis by nephritic factor sera.,"PW Mathieson, R Würzner, DB Oliveria, PJ Lachmann, DK Peters","Journal of Experimental Medicine 177 (6), 1827-1831",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4328324162453491607,106,1993
Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein‐Barr virus transformation of the cells,"I McConnell, G Klein, TF Lint, PJ Lachmann","European journal of immunology 8 (7), 453-458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11906673292985722743,106,1978
Inherited deficiencies of the terminal components of human complement.,"R Würzner, A Orren, PJ Lachmann","Immunodeficiency reviews 3 (2), 123-147",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4488040967527227022,105,1992
The immunogloblin nature of nephritic factor (NeF).,"DM Scott, N Amos, JG Sissons, PJ Lachmann, DK Peters","Clinical and experimental immunology 32 (1), 12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5263639017170102244,105,1978
The behaviour of complement and platelets in lethal endotoxin shock in rabbits,"DL Brown, PJ Lachmann","International Archives of Allergy and Immunology 45 (1-2), 193-205",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12907854137848022489,105,1973
Correlation of antinuclear antibodies and nuclear staining patterns,"PJ Lachmann, HG Kunkel","The Lancet 278 (7199), 436-437",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18132800176282223024,104,1961
A library of oligosaccharide probes (neoglycolipids) from N-glycosylated proteins reveals that conglutinin binds to certain complex-type as well as high mannose-type …,"T Mizuochi, RW Loveless, AM Lawson, W Chai, PJ Lachmann, RA Childs, ...","Journal of Biological Chemistry 264 (23), 13834-13839",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8291466575991613681,101,1989
"Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases","MJ Walport, PJ Lachmann",Arthritis & Rheumatism: Official Journal of the American College of …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1539743881730502353,101,1988
Three rat monoclonal antibodies to human C3.,"PJ Lachmann, RG Oldroyd, C Milstein, BW Wright","Immunology 41 (3), 503",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11990745198211310520,101,1980
The immunological specificity of a macrophage inhibition factor,"HE Amos, PJ Lachmann","Immunology 18 (2), 269",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18276773489013961762,100,1970
"The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits","DL Brown, PJ Lachmann, JV Dacie","Clinical and experimental immunology 7 (3), 401",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16726604600568613019,97,1970
A second case of human C3b inhibitor (KAF) deficiency.,"RA Thompson, PJ Lachmann","Clinical and experimental immunology 27 (1), 23",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16475047730089466505,95,1977
New biological activity following intravascular activation of the complement cascade,"CE McCall, LR de Chatelet, D BROWN, P LACHMANN","Nature 249 (5460), 841",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10228892229713671045,95,1974
Venom‐specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings,"PW Ewan, J Deighton, AB Wilson, PJ Lachmann","Clinical & Experimental Allergy 23 (8), 647-660",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11197537927234856653,94,1993
"Phase 1 study of single agent CC-292, a highly selective Bruton's tyrosine kinase (BTK) inhibitor, in relapsed/refractory chronic lymphocytic leukemia (CLL)","WA Harb, BT Hill, J Gabrilove, JP Sharman, MT Schreeder, PM Barr, ...","Blood 122 (21), 1630-1630","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16623626975044274808,3823033921301824629",91,2013
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animals,"PJ Lachmann, L Strangeways, A Vyakarnam, G Evan","Ciba Found Symp 119, 25-57",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12084227649191844158,88,1986
Inherited structural variation and linkage relationships of C7,"MJ Hobart, V Joysey, PJ Lachmann","International Journal of Immunogenetics 5 (3), 157-163",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7814929800418465990,87,1978
Inhibition by metals of X-ray and ultraviolet-induced DNA repair in human cells,"RD Snyder, GF Davis, PJ Lachmann","Biological trace element research 21 (1), 389-398",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7833221070783322850,86,1989
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59.,"M Parizade, R Arnon, PJ Lachmann, Z Fishelson","Journal of Experimental Medicine 179 (5), 1625-1636",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8848955851581591863,85,1994
The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins,"BA Fernie‐King, DJ Seilly, PJ Lachmann","Immunology 111 (4), 444-452",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18016722553631694633,83,2004
Leukocytes from four patients with complete or partial Leu-CAM deficiency contain the common beta-subunit precursor and beta-subunit messenger RNA.,"N Dana, LK Clayton, DG Tennen, MW Pierce, PJ Lachmann, SA Law, ...","The Journal of clinical investigation 79 (3), 1010-1015",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15594890221801047700,82,1987
Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.,"M Walport, YC Ng, PJ Lachmann","Clinical and experimental immunology 69 (3), 501",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8341176655296888774,81,1987
Bispecific antibody: a tool for diagnosis and treatment of disease,"S Songsivilai, PJ Lachmann","Clinical & Experimental Immunology 79 (3), 315-321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2764039880292654509,80,1990
Deficiency of the effector mechanisms of the immune response and au toimmu n ity,"PJ Lachmann, MJ Walport","AUTOIMMUNITY AND AUTOIMMUNE, 149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4248455153439625434,79,1987
Dissociable neural systems supporting knowledge about human character and appearance in ourselves and others,"JM Moran, SM Lee, JDE Gabrieli","Journal of cognitive neuroscience 23 (9), 2222-2230","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4627966144477568091,453184228112435377",78,2011
Combined genetic deficiency of C6 and C7 in man.,"PJ Lachmann, MJ Hobart, P Woo","Clinical and experimental immunology 33 (2), 193",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17042915402263329012,78,1978
The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation,"P Bird, PJ Lachmann","European journal of immunology 18 (8), 1217-1222",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14926971189661362825,77,1988
"The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b)","JD Gitlin, FS Rosen, PJ Lachmann","Journal of Experimental Medicine 141 (5), 1221-1226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18414425157815914316,77,1975
The paraproteins in systemic capillary leak syndrome,"W Zhang, PW Ewan, PJ Lachmann","Clinical & Experimental Immunology 93 (3), 424-429",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=117041903064394524,76,1993
"Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products","TC Farries, PJ Lachmann, RA Harrison","Biochemical Journal 252 (1), 47-54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17808769306776065488,75,1988
Complement genetics in relation to HLA,"PJ Lachmann, MJ Hobart","British medical bulletin 34 (3), 247-252",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4571220599682910828,75,1978
Regulation of complement,"TE Mollnes, PJ Lachmann","Scandinavian journal of immunology 27 (2), 127-142",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6546452984472814502,74,1988
Complement-mediated lysis of liposomes produced by thereactive lysis' procedure,"PJ Lachmann, EA Munn, G Weissmann","Immunology 19 (6), 983",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1566020856662163974,72,1970
Studies on the terminal stages of complement lysis,"PJ Lachmann, DE Bowyer, P Nicol, RMC Dawson, EA Munn","Immunology 24 (1), 135",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9726116073994612089,71,1973
Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation,"F Santoro, PJ Lachmann, A Capron, M Capron","The Journal of Immunology 123 (4), 1551-1557",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=630784860053811406,70,1979
Handbook of experimental immunology,"PJ Lachmann, MJ Hobart, WP Aston","Blackwell, London",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=585684657023264893,70,1978
"Dysfunctional C1-inhibitor (At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 ‘reactive centre’(Arg444→ His) mutation","KS Aulak, PA Pemberton, FS Rosen, RW Carrell, PJ Lachmann, ...","Biochemical Journal 253 (2), 615-618",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1005019162985924023,67,1988
Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.,"JB Ziegler, CA Alper, RS Rosen, PJ Lachmann, L Sherington","The Journal of clinical investigation 55 (3), 668-672",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3806013026676832953,67,1975
A comparison of some properties of bovine conglutinin with those of rabbit immuno-conglutinin,PJ Lachmann,"Immunology 5 (6), 687",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2664292601027439576,67,1962
The structural basis for neutrophil inactivation of C1 inhibitor,"PA Pemberton, RA Harrison, PJ Lachmann, RW Carrell","Biochemical Journal 258 (1), 193-198",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13997232856325197431,66,1989
Ultrastructure and composition of bovine conglutinin,"CJ Strang, HS Slayter, PJ Lachmann, AE Davis","Biochemical Journal 234 (2), 381-389",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17832206687513696699,66,1986
Clinical aspects of immunology,"PJ Lachmann, DK Peters",Blackwell Scientific Publications,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5119323310091665797,66,1982
The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies,"PG Frost, PJ Lachmann","Clinical and experimental immunology 3 (5), 447",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5785090528140797289,66,1968
Two-domain structure of the native and reactive centre cleaved forms of C1 inhibitor of human complement by neutron scattering,"SJ Perkins, KF Smith, S Amatayakul, D Ashford, TW Rademacher, ...","Journal of molecular biology 214 (3), 751-763",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8317777673831997850,65,1990
Neutrophil Fcγ and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes,"JK Voice, PJ Lachmann","European journal of immunology 27 (10), 2514-2523",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11695152631034677215,64,1997
"Bovine serum conglutinin is a lectin which binds non-reducing terminal N-acetylglucosamine, mannose and fucose residues","RW Loveless, T Feizi, RA Childs, T Mizuochi, MS Stoll, RG Oldroyd, ...","Biochemical Journal 258 (1), 109-113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10709988570102194694,64,1989
Bovine conglutinin is a collagen-like protein,"AE Davis III, PJ Lachmann","Biochemistry 23 (10), 2139-2144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15460549848422944937,62,1984
"The purification of specific antibody as F (ab′) 2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens",PJ Lachmann,"Immunochemistry 8 (1), 81-88",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2295105890410085475,62,1971
Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.,"MG Wing, J Zajicek, DJ Seilly, DA Compston, PJ Lachmann","Immunology 76 (1), 140","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10363303290133482993,6158156270551616761",61,1992
Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus,"F Moldenhauer, J David, AHL Fielder, PJ Lachmann, MJ Walport",Arthritis & Rheumatism: Official Journal of the American College of …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1775027288628929346,61,1987
Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1,"D Davis, DM Stephens, C Willers, PJ Lachmann","Journal of general virology 71 (12), 2889-2898",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9310048779445802002,60,1990
Genetic defects of complement in man,"PJ Lachmann, FS Rosen","Springer Seminars in Immunopathology 1 (4), 339-353",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14257294767080990053,60,1978
Complement and immunity to viruses,"PJ Lachmann, A Davies","Immunological reviews 159 (1), 69-77",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12582573445774450978,59,1997
A family study of hereditary angioneurotic oedema,"P Beck, D Wills, GT Davies, PJ Lachmann, M Sussman","QJM: An International Journal of Medicine 42 (2), 317-339",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5908392584094951576,59,1973
An evolutionary view of the complement system,PJ Lachmann,"Behring Inst. Mitt 63, 25-37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9396260969525915105,58,1979
Immunity deficiency in pathogenesis of glomerulonephritis,"DK Peters, PJ Lachmann","The Lancet 303 (7846), 58-60",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7699480276362229537,58,1974
The appearance of migration inhibition factor and a mitogen in lymph draining tuberculin reactions,"JB Hay, PJ Lachmann, Z Trnka","European Journal of Immunology 3 (3), 127-131",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7930708352360808729,58,1973
Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7.,"R Würzner, VC Joysey, PJ Lachmann","The Journal of Immunology 152 (9), 4624-4629",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18295849898751906849,57,1994
The failure to show a necessary role for C3 in the ,"H Waldmann, PJ Lachmann","European journal of immunology 5 (3), 185-193",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11066560418271789436,57,1975
Hereditary angio‐oedema: a review with particular reference to pathogenesis and treatment,"K HADJIYANNAKI, PJ Lachmann","Clinical & Experimental Allergy 1 (2), 221-233",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11402148707629059878,57,1971
"Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.","S Meri, BP Morgan, M Wing, J Jones, A Davies, E Podack, PJ Lachmann","Journal of Experimental Medicine 172 (1), 367-370",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16767031288411086833,56,1990
Acquired C¯ 1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities,"G Hauptmann, JM Lang, ML North, F Oberling, G Mayer, P Lachmann","Blut: Zeitschrift für die Gesamte Blutforschung 32 (3), 195-206",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14739088836326349586,56,1976
Microbial subversion of the immune response,PJ Lachmann,"Proceedings of the National Academy of Sciences 99 (13), 8461-8462",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12003164352424563488,55,2002
A systematic study of neutrophil degranulation and respiratory burst ,"W Zhang, J Voice, PJ Lachmann","Clinical & Experimental Immunology 101 (3), 507-514",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15304381287235780120,55,1995
Preparing serum for functional complement assays,PJ Lachmann,"Journal of immunological methods 352 (1-2), 195-197",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17242997100551730581,54,2010
Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation,"PA Gatenby, JE Barbosa, PJ Lachmann","Clinical & Experimental Immunology 79 (2), 158-163",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6973848048765057721,52,1990
Deficiency of factor B of the complement system in sickle cell anaemia.,"WA Wilson, GR Hughes, PJ Lachmann","Br Med J 1 (6006), 367-369",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13718870605640339234,51,1976
Lesions due to complement in lipid membranes,"TR Hesketh, RR Dourmashkin, SN Payne, JH Humphrey, PJ Lachmann","Nature 233 (5322), 620",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15455697113286642078,51,1971
Hereditary angio‐oedema treated with e‐aminocaproic acid,"RH Champion, PJ Lachmann","British Journal of Dermatology 81 (10), 763-765",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10979223481033685948,51,1969
Nomenclature of complement,World Health Organization,"Bulletin of the World Health Organization (WHO) 39 (6), 934-8","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14691912476702952652,17184954068839336669",51,1968
An iatrogenic autoantibody: immunological responses topituitary snuff'in patients with diabetes insipidus,"J Pepys, PA Jenkins, PJ Lachmann, WE Mahon","Clinical and experimental immunology 1 (4), 377",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3302869184927736154,51,1966
Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.,"W Zhang, PJ Lachmann","Immunology 81 (1), 137",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11754792964157230396,50,1994
Resolution and analysis of ‘native’and ‘activated’properdin,"TC Farries, JT Finch, PJ Lachmann, RA Harrison","Biochemical Journal 243 (2), 507-517",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11003940133790915513,50,1987
"The complement‐inhibiting protein, Protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells","IA Rooney, A Davies, D Griffiths, JD Williams, M Davies, S Meri, ...","Clinical & Experimental Immunology 83 (2), 251-256",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16804201863482707814,49,1991
Coupling PPD to tumour cells enhances their antigenicity in BCG-primed mice,"PJ Lachmann, K Sikora","Nature 271 (5644), 463-464",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15122113089463801042,49,1978
Studies on antigenic competition: II. Abolition of antigenic competition by antibody against or tolerance to the dominant antigen: a model for antigenic competition,"MJ Taussig, PJ Lachmann","Immunology 22 (2), 185",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2725522029107157941,49,1972
Effect of inhibition of polyamine biosynthesis by DL-α-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo,"PS Sunkara, CC Chang, NJ Prakash, PJ Lachmann","Cancer research 45 (9), 4067-4070",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6380071914989997834,47,1985
Interaction between host complement and mosquito-midgut-stage Plasmodium berghei,"G Margos, S Navarette, G Butcher, A Davies, C Willers, RE Sinden, ...","Infection and immunity 69 (8), 5064-5071",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10217986744451243073,46,2001
An attempt to characterize the lupus erythematosus cell antigen,PJ Lachmann,"Immunology 4 (2), 153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12510968729931265867,46,1961
Attribution of the various inhibitory actions of the streptococcal inhibitor of complement (SIC) to regions within the molecule,"MJ Binks, BA Fernie-King, DJ Seilly, PJ Lachmann, KS Sriprakash","Journal of Biological Chemistry 280 (20), 20120-20125",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12251182150123365447,43,2005
Lupus and desoxyribonuclease,PJ Lachmann,"Lupus 12 (3), 202-206",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13275715842303444655,43,2003
The catabolism of C1 (-)-inhibitor and the pathogenesis of hereditary angio-edema.,"PJ Lachmann, FS Rosen","Acta pathologica, microbiologica, et immunologica Scandinavica. Supplement …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2803946636434500748,43,1984
Novel cleavage products of the third component of human complement,"RA Harrison, PJ Lachmann","Molecular immunology 17 (2), 219-228",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11935365922950520193,43,1980
Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis,"DG Williams, PJ Lachmann, JA Charlesworth, DK Peters, DR Peters","The Lancet 301 (7801), 447-449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12604539780908904338,43,1973
Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6.,"R Würzner, MJ Hobart, BA Fernie, D Mewar, PC Potter, A Orren, ...","The Journal of clinical investigation 95 (4), 1877-1883",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15995374413942967126,42,1995
"Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement","TC Farries, PJ Lachmann, RA Harrison","Biochemical Journal 253 (3), 667-675",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5598693569137626293,42,1988
Human clones with natural killer function can activate B cells and secrete B cell differentiation factors,"A Vyakarnam, MK Brenner, JE Reittie, CH Houker, PJ Lachmann","European journal of immunology 15 (6), 606-610",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16106263220857383123,42,1985
The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar …,"D Davis, B Chaudhri, DM Stephens, CA Carne, C Willers, PJ Lachmann","Journal of General Virology 71 (9), 1975-1983",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4982188316588826546,41,1990
Is IgM-like dislocation a common feature of antibody function?,DR Burton,"Immunology today 7 (6), 165-167",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7017157082936661996,41,1986
C6: synthesis by the liver in vivo.,"MJ Hobart, PJ Lachmann, RY Calne","Journal of Experimental Medicine 146 (2), 629-630",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16739055627294768874,41,1977
Recognition of complex carbohydrates by the macrophage mannose receptor,ME Taylor,"Biochemical Society transactions 21 (2), 468-473",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14513843753355699130,40,1993
Purification of cobra venom factor from phospholipase A contaminant.,"PJ Lachmann, L Halbwachs, A Gewurz, H Gewurz","Immunology 31 (6), 961",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10465443762526950084,39,1976
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection,"YM Ali, A Hayat, BM Saeed, KS Haleem, S Alshamrani, HI Kenawy, ...","Proceedings of the National Academy of Sciences 111 (14), 5301-5306",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15268790084555465127,38,2014
Complement before molecular biology,P Lachmann,"Molecular immunology 43 (6), 496-508",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7213048374740863798,38,2006
Detection of IgA antibodies by the red cell linked antigen-antiglobulin reaction: antibodies in the sera of infants to milk proteins,"RRA Coombs, WE Jonas, PJ Lachmann, A Feinstein","International Archives of Allergy and Immunology 27 (6), 321-337",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12900245207105524207,38,1965
A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom,"AB Wilson, J Deighton, PJ Lachmann, PW Ewan","Allergy 49 (4), 272-280",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14081094649299346563,37,1994
Conglutinin binding polyethylene glycol precipitation assay for immune complexes.,"M Macanovic, PJ Lachmann","Clinical and experimental immunology 38 (2), 274",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7790440480558617029,37,1979
"Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis","PW Ewan, PJ Lachmann","Clinical and experimental immunology 30 (1), 22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4834507691318872315,37,1977
Complement and cell membranes,"I McConnell, PJ Lachmann","Immunological Reviews 32 (1), 72-92",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1557788072711209495,37,1976
Cellular immunity in subacute sclerosing panencephalitis,"H Valdimarsson, G Agnarsdottir, PJ Lachmann","Proceedings of the Royal Society of Medicine 67 (11), 1125-1129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6259644513103212164,37,1974
A sedimentation pattern technique for measuring conglutination: its application to demonstrating immunoconglutinins to C′ 4,PJ Lachmann,"Immunology 11 (3), 263",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2598982468423138668,37,1966
Lymphocyte cooperation,PJ Lachmann,Proceedings of the Royal Society of London. Series B. Biological Sciences …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12445079963819752762,36,1971
The origin of an antigenic zone surrounding HeLa cells cultured on glass,"L Weiss, PJ Lachmann","Experimental cell research 36 (1), 86-91",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8445487418091755833,36,1964
Taking complement to the clinic–has the time finally come?,"PJ Lachmann, RAG Smith","Scandinavian journal of immunology 69 (6), 471-478",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14791912546334174876,35,2009
Sequence‐specific,"CM Fletcher, RA Harrison, PJ Lachmann, D Neuhaus","Protein Science 2 (12), 2015-2027",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5083585722149792373,35,1993
Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.,"P Woo, PJ Lachmann, RA Harrison, N Amos, C Cooper, FS Rosen","Clinical and experimental immunology 61 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3479724967572864548,35,1985
Immunopathology of measles,PJ Lachmann,"Proceedings of the Royal Society of Medicine 67 (11), 1120-1122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3826953649714626190,35,1974
Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59,"WD Ratnoff, JJ Knez, GM Prince, H Okada, PJ Lachmann, ME Medof","Clinical & Experimental Immunology 87 (3), 415-421",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10111080090800238800,34,1992
Inherited complement deficiencies,PJ Lachmann,"Philosophical Transactions of the Royal Society of London. B, Biological …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17951721199162135360,34,1984
"Lymphocytotropic strains of HIV type 1 when complexed with enhancing antibodies can infect macrophages via FcγRIII, independently of CD4","H TRISCHMANN, D DAVIS, PJ LACHMANN","AIDS research and human retroviruses 11 (3), 343-352",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16572090228824983271,33,1995
Thiol involvement in the inhibition of DNA repair by metals in mammalian cells.,"RD Snyder, PJ Lachmann","Molecular toxicology 2 (2), 117-128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5085669376641280949,33,1989
Cyclic AMP reduces and cyclic GMP increases the traffic of lymphocytes through peripheral lymph nodes of sheep in vivo.,"TC Moore, PJ Lachmann","Immunology 47 (3), 423",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8136540062334956734,33,1982
Factor B of the alternative complement pathway on human lymphocytes,"L Halbwachs, PJ Lachmann","Scandinavian journal of immunology 5 (6‐7), 697-704",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4663356899197176907,33,1976
Molecular bases of combined subtotal deficiencies of C6 and C7: their effects in combination with other C6 and C7 deficiencies.,"BA Fernie, R Würzner, A Orren, BP Morgan, PC Potter, AE Platonov, ...","The Journal of Immunology 157 (8), 3648-3657",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12858681612940516495,32,1996
CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients,"JE Teixeira, RS Costa, PJ Lachmann, R Würzner, JE Barbosa","Clinical & Experimental Immunology 105 (3), 497-503",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3088594310926124342,32,1996
An anti‐peptide antibody that recognizes a neo‐antigen in the CR1 stump remaining on erythrocytes after proteolysis,"JE Barbosa, RA Harrison, PJ Barker, PJ Lachmann","Clinical & Experimental Immunology 87 (1), 144-149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=344798217469717600,32,1992
Lymphocyte‐associated complement: Role of C8 in certain cell‐mediated lytic reactions,"P Perlmann, H Perlmann, P Lachmann","Scandinavian journal of immunology 3 (1), 77-84",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13621089285324411304,32,1974
Evolution of mutation rate and virulence among human retroviruses,PW Ewald,Philosophical Transactions of the Royal Society of London. Series B …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10323346715674944538,31,1994
Immunoconglutinins in human saliva—a group of unusual IgA antibodies,"PJ Lachmann, RA Thomson","Immunology 18 (2), 157",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13323841306889263083,31,1970
C6-deficiency in rabbits,PJ Lachmann,"Protides of the biological fluids 17, 301-309",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14277339988925664726,31,1970
"Complement, Conglutinin and Immuno‐Conglutinins","PJ Lachmann, RRA Coombs","Ciba Foundation Symposium‐Complement, 242-280",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10300568197477840645,31,1965
Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiency.,"A Orren, R Würzner, PC Potter, BA Fernie, S Coetzee, BP Morgan, ...","Immunology 75 (1), 10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9578635496103669106,30,1992
"Lymphosarcoma, Cold Urticaria, IgG","G Hauptmann, JM Lang, ML North, FR Oberling, G Mayer, PJ Lachmann","Scandinavian journal of haematology 15 (1), 22-26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16558647879005396738,30,1975
Public health and bioethics,PJ Lachmann,"The Journal of medicine and philosophy 23 (3), 297-302",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16131967946009088884,29,1998
The use of animals in research: medical progress depends on it,P Lachmann,"British Medical Journal 305 (6844), 1-2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1901039910903450521,29,1992
Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells …,"DY Sia, PJ Lachmann, KN Leung","Immunology 51 (4), 755",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4199121051330750450,29,1984
Use of monoclonal anti‐C3 antibodies to characterise the fragments of C3 that are found on erythrocytes,"PJ Lachmann, D Voak, RG Oldroyd, DM Downie, PC Bevan","Vox sanguinis 45 (5), 367-372",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1193569612641583686,29,1983
An improved purification procedure for the third component of complement and β1H globulin from human serum,"RA Harrison, PJ Lachmann","Molecular immunology 16 (10), 767-776",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17770667375778121371,29,1979
Linkage studies with C6,"MJ Hobart, PJL Cook, PJ Lachmann","International Journal of Immunogenetics 4 (6), 423-428",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12602861123223995949,29,1977
A sensitive assay for cellular hypersensitivity based on the uptake of radioactive colloidal gold,"CJ Meade, PJ Lachmann, S Brenner","Immunology 27 (2), 227",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11139667154295913130,29,1974
A two-stage indirect LE cell test,PJ Lachmann,"Immunology 4 (2), 142",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9470390726234501035,29,1961
Complement deficiencies and abnormalities of the complement system in systemic lupus erythematosus and related disorders,"MJ Walport, PJ Lachmann","Current opinion in rheumatology 2 (4), 661-663",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14768087685537319917,28,1990
Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.,"W Emlen, G Burdick, V Carl, PJ Lachmann","The Journal of Immunology 142 (12), 4366-4371",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12324713046384527609,28,1989
Treatment of systemic capillary leak syndrome,"PW Ewan, PJ Lachmann, AH Morice, PJG Forster, CJ Doorenbos","The Lancet 332 (8626), 1496",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4176779750892728295,28,1988
IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis.,"PW Ewan, PJ Lachmann","Clinical and experimental immunology 35 (2), 227",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12292542952246258798,28,1979
"Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities","BA Fernie-King, DJ Seilly, MJ Binks, KS Sriprakash, PJ Lachmann","Microbes and infection 9 (3), 300-307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11488095510676764921,27,2007
Stem cell research—why is it regarded as a threat? An investigation of the economic and ethical arguments made against research with human embryonic stem cells,P Lachmann,"EMBO reports 2 (3), 165-168",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15803991372489669233,27,2001
Immunology: Are complement lysis and lymphocytotoxicity analogous?,PJ Lachmann,"Nature 305 (5934), 473",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4301706911708209665,27,1983
HEBERDEN ORATION 1986: COMPLEMENT—FRIEND OR FOE?,PJ Lachmann,"Rheumatology 26 (6), 409-415",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2040734436745952520,26,1987
Restoration of specific immunological virginity,"I McConnell, PJ Lachmann, MJ Hobart","Nature 250 (5462), 113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9864758422209293273,26,1974
The Breakdown of Embryonic (Chick) Cartilage and Bone Cultivated in the Presence of Complement-Sufficient Antiserum,"PJ Lachmann, RRA Coombs, HB Fell, JT Dingle","International Archives of Allergy and Immunology 36 (5), 469-485",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12794909809467064838,26,1969
Specific selection of antigen-reactive lymphocytes into antigenically stimulated lymph nodes in sheep.,"J Hopkins, I McConnell, PJ Lachmann","Journal of Experimental Medicine 153 (3), 706-719",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6495149426304168157,25,1981
Lymphocyte traffic through lymph nodes during cell shutdown,"I McConnell, J Hopkins, P Lachmann",Blood Cells and Vessel Walls: Functional Interactions. Ciba Foundation …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5374791460398404451,25,1980
Activation of the third component of complement (C3) detected by a monoclonal anti-C3 ‘g’neoantigen antibody in a one-step enzyme immunoassay,"TE Mollnes, PJ Lachmann","Journal of immunological methods 101 (2), 201-207",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9634894804667100019,24,1987
Further studies of the C3g component of the alpha 2D fragment of human C3.,"H Chaplin, MC Monroe, PJ Lachmann","Clinical and experimental immunology 51 (3), 639",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8805393187627020660,24,1983
Immunoconglutinins and C3 in human saliva.,"BD Williams, SJ Challacombe, JM Slaney, PJ Lachmann, T Lehner","Clinical and experimental immunology 19 (3), 423",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6602809043218536491,24,1975
Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways.,"W Zhang, PJ Lachmann","The Journal of Immunology 156 (7), 2599-2606",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9773584891332821369,23,1996
A novel strategy for producing chimeric bispecific antibodies by gene transfection,"S Songsivilai, PM Clissold, PJ Lachmann","Biochemical and biophysical research communications 164 (1), 271-276",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5459333277993899051,23,1989
"Differential effects of 5-azacytidine and 5-azadeoxycytidine on cytotoxicity, DNA-strand breaking and repair of X-ray-induced DNA damage in HeLa cells","RD Snyder, PJ Lachmann","Mutation Research Letters 226 (3), 185-190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9494842986290092623,23,1989
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro.,"N Amos, JG Sissons, JF Girard, PJ Lachmann, DK Peters","Clinical and experimental immunology 24 (3), 474",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3854814427247042231,23,1976
Genetic deficiencies of the complement system,PJ Lachmann,"Ontogeny of Acquired Immunity, 193-208",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12069065239176868775,23,1972
The preparation and properties of alexinated intermediates that react with conglutinin: I. Guinea-pig complement,"PJ Lachmann, R Liske","Immunology 11 (3), 243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6941115405611897679,23,1966
The in vivo destruction of antigen—a tool for probing and modulating an autoimmune response,PJ Lachmann,"Clinical and experimental immunology 106 (2), 187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13085319498220861325,22,1996
A physical map of the C6 and C7 complement component gene region on chromosome 5p13,"MJ Hobart, BA Fernie, RG DiSciplo, PJ Lachmann","Human molecular genetics 2 (7), 1035-1036",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11065523795101722739,22,1993
Hopeful genes and immunology,"DE McFarlin, PJ Lachmann","Nature 341 (6244), 693",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17817936684953745528,22,1989
The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the …,"MC Poznansky, PM Clissold, PJ Lachmann","The Journal of Immunology 143 (4), 1254-1258",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2635580965063580064,22,1989
Immunology: A common form of killing,PJ Lachmann,"Nature 321 (6070), 560-560",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=127804695046340164,22,1986
The relation of deoxyribonuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB/NZW mice,"K Hadjiyannaki, PJ Lachmann","Clinical and experimental immunology 11 (2), 291",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7805851319455553069,22,1972
Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2,"S Yaseen, G Demopulos, T Dudler, M Yabuki, CL Wood, WJ Cummings, ...","The FASEB Journal 31 (5), 2210-2219",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12444643599305190436,21,2017
Inhibition of antimicrobial peptides by group A streptococci: SIC and DRS,"BA Fernie-King, DJ Seilly, PJ Lachmann","Biochemical Society Transactions 34 (2), 273-275",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7316352960059673578,21,2006
"The profiles of interleukin (IL)‐2, IL‐6, and interferon‐gamma production by peripheral blood mononuclear cells from house‐dust‐mite‐allergic patients: a role for IL‐6 in …","SM McHugh, AB Wilson, J Deighton, PJ Lachmann, PW Ewan","Allergy 49 (9), 751-759",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5962781926636090536,21,1994
Extracts of wheat gluten activate complement via the alternative pathway.,"DJ Unsworth, R Würzner, DL Brown, PJ Lachmann","Clinical and experimental immunology 94 (3), 539",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9954703020246003753,21,1993
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits.,"PD Hoeprich, CA Dahinden, PJ Lachmann, AE Davis, TE Hugli","Journal of Biological Chemistry 260 (5), 2597-2600",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=177444885686024335,21,1985
E. Complement The immunochemistry of complement,"PJ Lachmann, N surName",Proceedings of the Royal Society of London. Series B. Biological Sciences …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6527343919796093833,21,1969
The Fractionation of Antigen‐Dependent Macrophage Migration Inhibition and Macrophage Activation Factors from Lymph Draining a Tuberculin Reaction,"DM Lowe, PJ Lachmann","Scandinavian journal of immunology 3 (4), 423-432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6916825229087243317,20,1974
"The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals",PJ Lachmann,"QJM: An International Journal of Medicine 105 (12), 1179-1189",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10660535596722074164,19,2012
Health risks of genetically modified foods,H Schellekens,"The Lancet 354 (9172), 70-71",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9421297092722698804,19,1999
How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion,"R Würzner, AE Platonov, VB Beloborodov, AI Pereverzev, IV Vershinina, ...","Immunology 88 (3), 407-411",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9135804897659799017,19,1996
Molecular basis of the complement C7 M/N polymorphism. A neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15.,"R Würzner, BA Fernie, AM Jones, PJ Lachmann, MJ Hobart","The Journal of Immunology 154 (9), 4813-4819",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8514082127843564088,19,1995
A novel protein polymorphism of human complement C7 detected by a monoclonal antibody,"R Würzner, MJ Hobart, A Orren, K Tokunaga, R Nitze, O Götze, ...","Immunogenetics 35 (6), 398-402",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14850940545840115762,19,1992
Mechanisms of oligodendrocyte interaction with normal human serum-defining the role of complement,"J Zajicek, MG Wing, PJ Lachmann, DAS Compston","Journal of the neurological sciences 108 (1), 65-72",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6661041399177101411,19,1992
In vivo diminution by chelators of snake venom-provoked hemorrhage and in vitro inhibition of proteolytic activity,"E Giroux, PJ Lachmann","Toxicon 19 (4), 481-492",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14147042849392605377,19,1981
The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus …,"AP Manderson, F Carlucci, PJ Lachmann, RA Lazarus, RJ Festenstein, ...","Arthritis research & therapy 8 (3), R68",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15266994468889704063,18,2006
Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.,"RH Ward, PJ Lachmann","Immunology 56 (1), 179",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9858758720871743497,18,1985
Immunological studies on the cerebrospinal fluid in neurological sarcoidosis,"JD Mitchell, PL Yap, LA Milne, PJ Lachmann, B Pentland","Journal of neuroimmunology 7, 249-253",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3996753196290959995,18,1984
Complement receptors and cell associated complement components,"I McConnell, PJ Lachmann","Immunological communications 6 (2), 111-132",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17732143009189187668,18,1977
The mixed conglutination reaction,"PJ Lachmann, KW Sell, RL Spooner","Immunology 8 (4), 345",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16828385160066040394,18,1965
Study of the ,"ANAM FERREIRA, R WÜRZNER, MJ HOBART, PJ LACHMANN","Parasite immunology 17 (5), 245-251",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8212407360682720904,17,1995
Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased …,"D Davis, DM Stephens, CA Carne, PJ Lachmann","Journal of general virology 74 (12), 2609-2617",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7884402623044009088,17,1993
Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects.,"A Orren, RE Warren, PC Potter, AM Jones, PJ Lachmann, JT Poolman","Infection and immunity 60 (11), 4510-4516",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17116355994026836703,17,1992
Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons …,"DM Stephens, JW Eichberg, NL Haigwood, KS Steimer, D Davis, ...","Journal of general virology 73 (5), 1099-1106",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6773473692359817672,17,1992
Carrier Effect of Concanavalin A‐Reactive and‐Non‐Reactive Material in Tuberculin PPD,"M Harboe, HG Wiker, PJ Lachmann","Scandinavian journal of immunology 32 (3), 263-271",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12805363104267652036,17,1990
"Structure of C3f, a small peptide specifically released during inactivation of the third component of complement","RA Harrison, TC Farries, FD Northrop, PJ Lachmann, AE Davis","Complement 5, 27-32",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8958070357798720815,17,1988
Antibody and complement in viral infections,PJ Lachmann,"British medical bulletin 41 (1), 3-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17530107125477749321,17,1985
The activation of the C3b feedback cycle with human complement components. I. Through the classical pathway.,"LW Mak, PJ Lachmann, J Majewski","Clinical and experimental immunology 30 (2), 200",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10390285596189574710,17,1977
A mechanism of migration inhibition involving components of the coagulation system,"CJ Meade, PJ Lachmann, RM Binns","Scandinavian journal of immunology 5 (5), 529-539",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17407465799092585161,17,1976
Metabolism of radio-labelled C3: effects of in vivo activation in rabbits,"JA Charlesworth, DG Williams, P Naish, PJ Lachmann, DK Peters","Clinical and experimental immunology 16 (3), 445",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6334469422473004853,17,1974
Immunological reactions at the cell surface,"RRA Coombs, PJ Lachmann","British medical bulletin 24 (2), 113-117",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17998133190623939111,17,1968
The use of antibodies in the prophylaxis and treatment of infections,PJ Lachmann,"Emerging microbes & infections 1 (8), e11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4383989531291183489,16,2012
Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross‐linking of Fc,"W Zhang, B Bi, RG Oldroyd, PJ Lachmann","Clinical & Experimental Immunology 121 (1), 106-111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17115727373668108173,16,2000
"Hyperthermia, polyamine depletion, and inhibition of X-ray-induced DNA strand break repair","RD Snyder, PJ Lachmann","Radiation research 120 (1), 121-128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14897067502694022424,16,1989
"Close linkage between mouse genes determining the two forms of complement component C6 and component C7, and ","A Orren, MJ Hobart, HR Nash, PJ Lachmann","Immunogenetics 21 (6), 591-599",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9984106375980493372,16,1985
Potentiation of antitumor and antimetastatic activities of α-difluoromethylornithine by interferon inducers,"PS Sunkara, NJ Prakash, AL Rosenberger, AC Hagan, PJ Lachmann, ...","Cancer research 44 (7), 2799-2802",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5782770185447526720,16,1984
"The genetics of the sixth and seventh components of complement in the dog: polymorphism, linkage, locus duplication, and silent alleles","PR Eldridge, MJ Hobart, PJ Lachmann","Biochemical genetics 21 (1-2), 81-91",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7919249461518277909,16,1983
Intracerebral synthesis of antibodies to measles and distemper viruses in patients with subacute sclerosing panencephalitis and multiple sclerosis.,"NT Gorman, J Habicht, PJ Lachmann","Clinical and experimental immunology 39 (1), 44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6398531569191188454,16,1980
The genetics of the complement system,"PJ Lachmann, MJ Hobart","Human genetics: possibilities and realities, 231-250",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14929309519918023990,16,1979
"The preparation and properties of alexinated intermediates that react with conglutinin: II. Equine, rabbit and human complement","PJ Lachmann, R Liske","Immunology 11 (3), 255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10771383254260090235,16,1966
Complotype affects the extent of down‐regulation by Factor I of the C3b feedback cycle ,"E Lay, S Nutland, JE Smith, I Hiles, RAG Smith, DJ Seilly, A Buchberger, ...","Clinical & Experimental Immunology 181 (2), 314-322",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15133285606126029647,15,2015
Complement component C6 and C7 haplotypes associated with deficiencies of C6,"BA Fernie, A Orren, R Würzner, AM Jones, PC Potter, PJ Lachmann, ...","Annals of human genetics 59 (2), 183-195",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10410404706984864717,15,1995
Complement deficiency and the pathogenesis of autoimmune immune complex disease,PJ Lachmann,"1939-1989: Fifty Years Progress in Allergy 49, 245-263",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15058849872413517070,15,1990
Initiation of complement activation,"PJ Lachmann, NC Hughes-Jones","Complement, 147-166",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4066624427540272068,15,1985
"Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B …","A Vyakarnam, PJ Lachmann","Immunology 53 (4), 601",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18444878336007937427,15,1984
C6–C7: A further “complement supergene”,"PJ Lachmann, MJ Hobart","The Journal of Immunology 120 (5), 1781-1782",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12583605965915892288,15,1978
The quantitation of C6 in rabbit and human sera,"F Tedesco, PJ Lachmann","Clinical and experimental immunology 9 (3), 359",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2288768104074790658,15,1971
Consent and confidentiality—where are the limits? An introduction,PJ Lachmann,"Journal of medical ethics 29 (1), 2-3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5204722260180111187,14,2003
A competitive inhibition ELISA for the quantification of human interferon-γ,"AB Wilson, SM McHugh, J Deighton, PW Ewan, PJ Lachmann","Journal of immunological methods 162 (2), 247-255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13581962373196111235,14,1993
The heterogenization of tumour cells with tuberculin. I. The coupling of tuberculin to cell surfaces using con-A as ligand.,"PJ Lachmann, A Vyakarnam, K Sikora","Immunology 42 (2), 329",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10647171326945396162,14,1981
Complement component C1q is sensitive to acute vitamin C defficiency in guinea pigs,"CJ Bates, CI Levene, RG Oldroyd, PJ Lachmann","Biochimica et Biophysica Acta (BBA)-General Subjects 540 (3), 423-430",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5265441694324732700,14,1978
Streptococcal infection in young pigs III. The immunity of adult pigs investigated by the bactericidal test,"KK Agarwal, SD Elliott, PJ Lachmann","Epidemiology & Infection 67 (3), 491-503",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9123507717973335192,14,1969
Crystal-ball gazing–the future of immunological research viewed from the cutting edge,"L Brent, IR Cohen, PC Doherty, M Feldmann, P Matzinger, ST Holgate, ...","Clinical and experimental immunology 147 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3638826573922360774,13,2007
Anti-DNA antibodies in the urine of lupus nephritis patients.,"M Macanovic, MB Hogarth, PJ Lachmann","Nephrology, dialysis, transplantation: official publication of the European …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16991907418076440035,13,1999
Microbial immunology: a new mechanism for immune subversion,PJ Lachmann,"Current biology 8 (3), R99-R101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5672712021108141233,13,1998
Herpes virus saimiri CD59-baculovirus expression and characterisation of complement inhibitory activity,"JC BRAMLEY, A DAVIES, PJ LACHMANN","Biochemical Society Transactions 25 (2), 354S-354S",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11942978409557738503,13,1997
The allotyping of complement components in whole serum by iso-electric focusing in gel followed by specific haemolytic assay,"MJ Hobart, PJ Lachmann","The Journal of Immunology 116 (6), 1736-1736",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2745005056511984628,13,1976
Further studies on the C3b inactivator or conglutinogen activating factor (KAF),"PJ Lachmann, P Nicol, WP Aston","Immunochemistry 10 (10), 695-700",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15933665224303038895,13,1973
The grandmother effect,PJ Lachmann,"Gerontology 57 (4), 375-377",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10817816941464583461,12,2011
Antibodies raised to short synthetic peptides with sequences derived from HIV‐1 SF2 gp120 can both neutralize and enhance HIV‐1 SF13: A later variant isolated from the same host,"D Davis, H Trischmann, DM Stephens, PJ Lachmann","Journal of medical virology 64 (3), 207-216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1489807968409972960,12,2001
GM food debate,A Mowat,"The Lancet 354 (9191), 1725",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13641671827743113584,12,1999
Structure of complement poly-C9 determined in projection by cryo-electron microscopy and single particle analysis,"G Biesecker, P Lachmann, R Henderson","Molecular immunology 30 (15), 1369-1382",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17928371626383505998,12,1993
Immunology of leishmaniasis,JM Blackwell,"Clinical aspects of immunology, 5th ed., in press. Blackwell Scientific …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6495282373224891612,12,1990
Studies with monoclonal antibodies to complement components.,PJ Lachmann,"Immunology today 2 (8), 144-144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1214567681581429102,12,1981
Efferent lymph output of lymphocytes following infusions of prostaglandin E2 and other vasoactive mediators into cannulated afferent popliteal lymphatics in sheep,TC Moore,"IRCS Med. Sci. 8, 272",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=432034715687704123,12,1980
Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.,"DM Scott, I McConnell, P Agomo, PJ Lachmann","Immunology 34 (4), 591",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7682061373214433056,12,1978
Variable region (Fv) determinants on mouse lymphocytes.,"I McConnell, PJ Lachmann, D Givol","Immunology 30 (6), 841",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1440207953276173296,12,1976
The use of antigen antibody precipitates for specific detection of antigens in tissue sections,"ED Wachsmuth, PJ Lachmann","Immunology 17 (3), 469",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15912485290216119234,12,1969
Persistent and inducible neogenesis repopulates progenitor renin lineage cells in the kidney,"L Hickmann, A Steglich, M Gerlach, M Al-Mekhlafi, J Sradnick, ...","Kidney international 92 (6), 1419-1432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=583121211421679202,11,2017
Peripheral blood mononuclear cells from house dust mite allergic patients produce IL‐2 in response to specific allergen challenge,"SM McHugh, PJ Lachmann, PW Ewan","Clinical & Experimental Allergy 23 (2), 137-144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=989050932120599801,11,1993
Cytostasis of different tumours by a murine PPD‐reactive CD4,"MG Wing, AMP Montgomery, C Harley, PJ Lachmann","Clinical & Experimental Immunology 82 (2), 208-213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6255501892408061297,11,1990
Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering,"SJ Perkins, KF Smith, AS Nealis, PJ Lachmann, RA Harrison","Biochemistry 29 (5), 1175-1180",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12326891706428363940,11,1990
Purified protein derivative (PPD),PJ Lachmann,"Springer seminars in immunopathology 10 (4), 301-304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11237935717297724531,11,1988
The Killing of Tumour Cell Targets Coupled to Tuberculin (PPD) by Human and Murine PPD‐Reactive T Helper Clones: I. PPD Specificity of Killing,"A Vyakarnam, PJ Lachmann, DY Sia","Scandinavian journal of immunology 27 (3), 337-346","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9669435425967053191,2190849574473298572,5567733707784665187",11,1988
Kidney and liver metallothioneins in rats after administration of an organic compound.,"E Giroux, PJ Lachmann","Journal of Biological Chemistry 259 (6), 3658-3662",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=196685124964132831,11,1984
Complement components on human lymphocytes,"AB Wilson, S Prichard-Thomas, BW Gurner, PJ Lachmann, RRA Coombs","Clinical immunology and immunopathology 22 (1), 118-127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12361511385767306403,11,1982
The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells.,"P Woo, PJ Lachmann","Immunology 44 (3), 629",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11991894037303420517,11,1981
The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative …,"A Vyakarnam, PJ Lachmann, K Sikora","Immunology 42 (2), 337",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8548713875586820481,11,1981
International collaborative study of four candidate reference preparations for the antigenic and hemolytic measurement of human serum complement components,"L Van Es, SJ Smith, PH Schur, G Hauptmann, W Leskovar, P Spath, ...","Journal of biological standardization 9 (1), 91-104",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=117849082550177815,11,1981
The physiological breakdown of C3b,"RA Harrison, PJ Lachmann","The Journal of Immunology 120 (5), 1777-1777",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3854416761970304307,11,1978
Using convalescent whole blood or plasma as passive immune therapy for the global war against Ebola,S Lu,"Emerging microbes & infections 3 (1), 1-3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=72144677752849091,10,2014
Subversion of the immune system by measles virus: a model for the intricate interplay between a virus and the human immune system,"D Gerlier, H Valentin, D Laine, C Rabourdin-Combe, C Servet-Delprat","Microbial Subversion of Immunity: Current Topics, 225-292",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17261387500199505038,10,2006
"Determination of CD59 protein in normal human serum by enzyme immunoassay, using octyl-glucoside detergent to release glycosyl-phosphatidylinositol-CD59 from lipid complex","APG Landi, AB Wilson, A Davies, PJ Lachmann, VPL Ferriani, DJ Seilly, ...","Immunology letters 90 (2-3), 209-213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3782596558160150532,10,2003
Difficulties in the ascertainment of C9 deficiency: lessons to be drawn from a compound heterozygote C9‐deficient subject,"MJ Hobart, BA Fernie, R Würzner, RG Oldroyd, RA Harrison, V Joysey, ...","Clinical & Experimental Immunology 108 (3), 500-506",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16906387010759309954,10,1997
Regulation of the activity of the transcription factors AP-I and NFAT during differentiation of precursor CD4+ T-cells into effector cells,"M Rincon, RA Flavell","Biochemical Society transactions 25 (2), 347-354",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8028742355071033453,10,1997
"Construction, expression and functional analysis of a glycolipid‐linked form of CR1","PM Clissold, HJ Ebling, PJ Lachmann","European journal of immunology 23 (9), 2346-2352",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13540627676931879634,10,1993
C6 epitope expression by an unrelated antisense cDNA clone: an inadvertent surface-simulation mimotope,"MJ Hobart, BA Fernie, KK Stanley, PJ Lachmann",Proceedings of the Royal Society of London. Series B: Biological Sciences …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11620324130786845878,10,1993
C7 M/N protein polymorphism typing applied to inherited deficiencies of human complement proteins C6 and C7,"R Würzner, N Rance, PC Potter, ML Hendricks, PJ Lachmann, A Orren","Clinical & Experimental Immunology 89 (3), 485-489",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9748817312844641492,10,1992
Chronic depression of lymphocyte traffic by long-term administration of prostaglandins to peripheral lymph nodes in sheep.,"TC Moore, PJ Lachmann","Surgery 95 (1), 45-51",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8792935136728392415,10,1984
Membrane attack by complement (with comments on cell-mediated cytotoxicity),MM Mayer,"Mechanisms of Cell-Mediated Cytotoxicity, 193-225",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=399382793983440065,10,1982
Nomenclature of complement,"KF Austen, EL Becker, CE Biro, T Borsos, AP Dalmasso, DIASDASI. W, ...","INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 37 (6), 660-+",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3668846153986381379,10,1970
Reactivity of antinuclear factors with DNA-nucleoproteins,PJ Lachmann,"Annals of the rheumatic diseases 23 (4), 311",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15924125142351845060,10,1964
Chicken ovalbumin upstream promoter transcription factor II regulates renin gene expression,"S Mayer, M Roeser, P Lachmann, S Ishii, JM Suh, S Harlander, M Desch, ...","Journal of Biological Chemistry 287 (29), 24483-24491",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4208573587212348588,9,2012
Anti-infective antibodies—reviving an old paradigm,P Lachmann,"Vaccine 27, G33-G37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7306625927411873564,9,2009
Subversion of the innate immune response by micro-organisms,"B Fernie-King, DJ Seilly, A Davies, PJ Lachmann","Annals of the rheumatic diseases 61 (suppl 2), ii8-ii12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13172469460341367955,9,2002
Comparison of C1q-receptors on rat microglia and peritoneal macrophages,"MG Wing, DJ Seilly, RS Nicholas, S Rahman, J Zajicek, PJ Lachmann, ...","Journal of neuroimmunology 94 (1-2), 74-81",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=361215646180904464,9,1999
Paradoxical reconstitution of complement activity following plasma transfusion of an individual with deficiency of the seventh component of complement.,"AE Platonov, R Würzner, B Beloborodov, AM Jones, DV Troshansky, ...","Immunology 81 (1), 142",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6508497807200416415,9,1994
"Human protec-tion (CD59), and 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers","S Men, BP Morgan, A Davies, RH Daniels, MG Olavesen, H Waldmann, ...","Immunology 71 (1), 1-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17332390205054507543,9,1990
Complement and disease.,PJ Lachmann,"Recenti progressi in medicina 79 (7-8), 293",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1592665227398192834,9,1988
Is the stepwise methylation of phosphatidylethanolamine relevant to the release of histamine from the mast cell?,"DSW BOAM, DR STANWORTH, SG SPANNER, GB ANSELL","Biochemical Society Transactions 12 (5), 782-783",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13905217217157139848,9,1984
"C3 receptors, complement deficiency and SLE","M WALPORT, P LACHMANN","Rheumatology 23 (1), 3-5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3905348525314864388,9,1984
HLA antigens in subacute sclerosing panencephalitis,"S Aysun, F Ersoy, Ö Sanal, K Yalaz, E Özdirim, AI Berkel, Y Renda","Archives of neurology 40 (1), 38-39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12518079333022084280,9,1983
Characterisation of the third component of canine and feline complement,"NT Gorman, I McConnell, PJ Lachmann","Veterinary immunology and immunopathology 2 (4), 309-320",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14004495950409982838,9,1981
In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.,"AB Wilson, PJ Lachmann, RR Coombs","Immunology 37 (1), 25",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5306300248279700784,9,1979
Clinical aspects of immunology,"PJ Lachmann, PGH Gell, RRA Coombs",Blackwell Scientific Publications,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2073138108359881385,9,1975
The reaction of sodium azide with fluorochromes,PJ Lachmann,"Immunology 7 (5), 507",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18127800137995897723,9,1964
An estimate of some molecular parameters of bovine conglutinin,"PJ Lachmann, CB Richards","Immunochemistry 1 (1), 37-41",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6701996080464922267,9,1964
Further studies of the down‐regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype,"PJ Lachmann, E Lay, DJ Seilly, A Buchberger, W Schwaeble, J Khadake","Clinical & Experimental Immunology 183 (1), 150-156",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17212963964019212747,8,2016
"Genetic and cultural evolution: from fossils to proteins, and from behaviour to ethics",P Lachmann,"European Review 18 (3), 297-309",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16649636257334161072,8,2010
Religion—An evolutionary adaptation,PJ Lachmann,"The FASEB Journal 24 (5), 1301-1307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12843621705867482645,8,2010
GM food debate,P Lachmann,"The Lancet 354 (9191), 1726",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8519257649360238984,8,1999
Cell surface engineering using a complement regulatory molecule modified with a synthetic myristoyl-electrostatic switch derivative,"RAG Smith, I Dodd, PJE Rowling, VF Cox, DE Mossakowska, RG Oldroyd, ...","Molecular Immunology 6 (35), 400",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3454949711098222626,8,1998
Importance of the third thrombospondin repeat of C6 for terminal complement complex assembly.,"R Würzner, D Mewar, BA Fernie, MJ Hobart, PJ Lachmann","Immunology 85 (2), 214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18348020334222971875,8,1995
A novel strategy for targeting CD4,"AMP Montgomery, MG Wing, PJ Lachmann","Clinical & Experimental Immunology 82 (2), 200-207",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1672830866716431902,8,1990
Genetic deficiency diseases of the complement system,"PJ LACHMANN, MJ WALPORT","Immunobiology of the complement system, 237-261",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15065778621760521374,8,1986
Tumour immunology: a review,PJ Lachmann,"Journal of the Royal Society of Medicine 77 (12), 1023-1029",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9331434476055038547,8,1984
In vitro modulation of viral cell surface glycoproteins by anti-viral antibody in the presence of complement.,"NT Gorman, PJ Lachmann","Clinical and experimental immunology 50 (3), 507",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16322401522845993516,8,1982
The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.,"PJ Lachmann, M Macanovic, GD Harkiss, RG Oldroyd, J Habicht","Clinical and experimental immunology 46 (2), 250",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17855544038111106425,8,1981
The coagglutination phenomenon of Bordet and Gengou involves a reaction between antibody-aggregated fourth component of complement and a receptor on guinea pig red cells,"RRA Coombs, AB Wilson, PJ Lachmann","International Archives of Allergy and Immunology 61 (4), 371-379",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9101304720299247652,8,1980
Auto-allergy,PJ Lachmann,"Clinical Aspects of Immunology, 859",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9309662438240313901,8,1975
TREATMENT OF SSPE WITH TRANSFER-FACTOR,"H Valdimarsson, G Agnarsdottir, PJ Lachmann","Archives of Neurology 32 (7), 503-503",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17769646383169136774,8,1975
The detection of Θ antigen on cells by immunofluorescence: Failure to detect Θ antigen on rosette‐forming cells,"SM Russell, M Ferrarini, A Munro, PJ Lachmann","European journal of immunology 2 (5), 456-459",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8161670466883025653,8,1972
Looking back on the alternative complement pathway,PJ Lachmann,"Immunobiology 223 (8-9), 519-523",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11781928840554168638,7,2018
Interference with Gsα-coupled receptor signaling in renin-producing cells leads to renal endothelial damage,"P Lachmann, L Hickmann, A Steglich, M Al-Mekhlafi, M Gerlach, ...","Journal of the American Society of Nephrology 28 (12), 3479-3489",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6362412406812936335,7,2017
C6 haplotypes: associations of a Dde I site polymorphism to complement deficiency genes and the Msp I restriction fragment length polymorphism (RFLP),"BA FFRNIE, MJ Hobart, G Delbridge, PC Potter, A Orren, PJ Lachmann","Clinical & Experimental Immunology 95 (2), 351-356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2876461452710970208,7,1994
C5b-9 binds to the N-terminal portion of CD59,"VPL Ferriani, RA Harrison, PJL Lachmann","Molecular Immunology 30, 10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12179936056472455799,7,1993
Overview: parasitism and immunology,JHL Playfair,Llachmann PJ et al. Clinical aspects of immunology. Boston: Blackwell …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5455406553351636793,7,1993
Protection against complement lysis,PJ LACHMANN,"Biochemical Society Transactions 18 (6), 1159-1160",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15117469893806704727,7,1990
Enzyme immunoassay detection of circulating immune complexes by monoclonal antibodies to C3 neoepitopes with special reference to IgG concentration and to interfering anti …,"P Garred, TE Mollnes, T Lea, PJ Lachmann","Journal of immunological methods 117 (1), 59-66",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10823047481903877197,7,1989
"C3B INACTIVATION-ISOLATION AND STRUCTURAL-ANALYSIS OF C3C, C3DG (ALPHA-2D), AND C3G","AE Davis, RA Harrison, PJ Lachmann","Immunobiology 164 (3-4), 231-232",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2865883718256933733,7,1983
Polymorphism of the third component of canine complement,"NT Gorman, MJ Hobart, PJ Lachmann","Veterinary Immunology and Immunopathology 2 (4), 301-307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5295639493045583718,7,1981
Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).,"AB Wilson, S Prichard-Thomas, PJ Lachmann, RR Coombs","Immunology 39 (2), 195",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13914086353144742809,7,1980
C1 inhibitor in malignant diseases,"PJ Lachmann, J Wragge-Morley","The Lancet 307 (7961), 703-704",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13719736796989673218,7,1976
Clinical effects of complement deficiency,PJ Lachmann,Advanced Medicine Series. 12th Symposium on Advanced Medicine. London …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8443059155561447948,7,1976
Genetics of the complement system.,P Lachmann,"Journal of medical genetics 12 (4), 372-377",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4249417138492623187,7,1975
"Abstracts of Papers Presented at the Third International Complement Workshop, Harvard Medical School, Boston, Massachusetts, June 3–5, 1968: Molecular Analysis of the Reaction …","NR Cooper, HJ Müller-Eberhard","The Journal of Immunology 101 (4), 813-814",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4807105953356544791,7,1968
A possible homeostatic mechanism in complement fixation: inhibition of the activity of fixed C′ 1 by the fixation of C′ 3a,PJ Lachmann,"Nature 210 (5032), 140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16021256024000937994,7,1966
Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum,"PJ Lachmann, E Lay, DJ Seilly","The FASEB Journal 32 (1), 123-129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8004786231139771833,6,2017
Neuronal protection of oligodendrocytes from antibody-independent complement lysis,"C Agoropoulou, SJ Piddlesden, PJ Lachmann, MG Wing","Neuroreport 9 (5), 927-932",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9026290600369786027,6,1998
Complement deficiencies: genetic and acquired,PJ Lachmann,"Clinical Aspects of Immunology, 1287-1304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5532327568334497394,6,1993
Complement genetics and host defence,PJ Lachmann,"Zentralblatt für Bakteriologie 274 (3), 316-324",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5733066594526728123,6,1990
Biological functions of the complement system,PJ LACHMANN,"Biochemical Society Transactions 18 (6), 1143-1145",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17905760400976394826,6,1990
An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent.,"DJ Samuel, PL Amlot, P Shepherd, PJ Lachmann","Clinical and experimental immunology 65 (2), 458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7212285006224516555,6,1986
Complement polymorphism and disease,"MJ Hobart, MJ Walport, PJ Lachmann","Clinics in immunology and allergy 4 (3), 647-664",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18351773086686975084,6,1984
Linkage studies in hereditary angio-oedema.,"EB Robson, PJ Lachmann, MJ Hobart, AW Johnston","Journal of medical genetics 16 (5), 347-350",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13246001617157781206,6,1979
The activation of the C3b feedback cycle with human complement components. II. Using components of the alternative pathway.,"LW Mak, J Majewski, PJ Lachmann","Clinical and experimental immunology 30 (2), 211",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17223580433089377959,6,1977
The C3 Feedback Cycle of C Activation: The Role of the C3b Inactivator (KAF),"PJ Lachmann, PAE Nicol","The Journal of Immunology 111 (1), 289-289",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18403618322190968169,6,1973
The reversible “dedifferentiation” of embryonic skeletal tissues in culture in response to complement-sufficient antiserum,"HB Fell, JT Dingle, RRA Coombs, PJ Lachmann","Differentiation and Immunology, 49-68",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13158303234270126452,6,1968
Complement in IgA immune-complex-induced neutrophil activation,"W Zhang, YM Lucisano, PJ Lachmann","Biochemical Society Transactions 25 (2), 462-466",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5442292902390048571,5,1997
The Immunology of Helminth Infections,AE Butterworth,"Lachman PJ, Peters SK, Rosen FS & Walport MJ. Clinical Aspects of Immunology …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12241961408165791800,5,1993
C7* N is a hypomorphic allele of the human complement c7 M/N protein polymorphism.,"R Würzner, K Tokunaga, R Nitze, O Götze, PJ Lachmann","Experimental and clinical immunogenetics 8 (3), 177-183",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15801430708005926058,5,1991
Antibody-dependent cytotoxicity on chicken red blood cell targets mediated by the U937 cell line.,"MB Villiers, RH Ward, PJ Lachmann","Immunology 61 (3), 277",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10427666505775090738,5,1987
LOSS OF COMPLEMENT RECEPTOR TYPE-1 FROM ERYTHROCYTES TRANSFUSED INTO PATIENTS WITH SLE OR HEMOLYTIC-ANEMIA,"MJ Walport, JC Newby, WJ Yount, PJ Lachmann","BRITISH JOURNAL OF RHEUMATOLOGY 25 (1), 109-110",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4196452671726911154,5,1986
ROLE OF POLYAMINES IN THE GROWTH AND DIFFERENTIATION OF B-16 MELANOMA-CELLS,"PS Sunkara, CC Chang, NJ Prakash, PJ Lachmann","JOURNAL OF CELL BIOLOGY 97 (5), A59-A59",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8086168154156838710,5,1983
Circulating immune complexes in Indian childhood cirrhosis.,"V Kalra, GD Harkiss, PJ Lachmann, OP Ghai","Clinical and experimental immunology 50 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12258336707288787189,5,1982
Production of MIF and mitogenic factor in vivo,"Z Trnka, JB Hay, PJ Lachmann","International Archives of Allergy and Immunology 45 (1-2), 292-294",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12880163066674449755,5,1973
Kinetic studies on the production of sensitized lymphocytes and soluble lymph node factors,"JB Hay, PJ Lachmann, Z Trnka",Proc. Seventh Leucocyte Culture Conference,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8290578803634970224,5,1973
It's ,"PJ Lachmann, JS Rowlinson","Astronomy & Geophysics 39 (3), 3.9-3.9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13729307623535551245,4,1998
Identification of MIC 11 antigen as an epitope of the CD59 molecule.,"A Davies, AB Wilson, JC Bramley, C Willers, V Van Heyningen, ...","Immunology 85 (2), 220",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14098907233315217840,4,1995
New aspect in inherited complement deficiencies in: Progress in immune deficiency III,"PJ Lachmann, HM Chapel, RJ Levisky",Royal Society of Medicine Servies Limited,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8115824245681473453,4,1991
"Plugs, burns and poisons",PJ Lachmann,"BioEssays 7 (5), 223-229",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11825839331475725807,4,1987
A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.,"PJ Lachmann, RM Grant, LS Freedman, K Sikora, NM Bleehen","British journal of cancer 51 (3), 415",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15976645055284445220,4,1985
Tissue-and metal-specific effects of thiolacrylic acids in rats,"E Giroux, PJ Lachmann, HG Petering, NJ Prakash, PJ Schechter","Biological trace element research 5 (2), 115-128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12870455938767222234,4,1983
Absence of variation in human C5,"M Amália Vaz‐Guedes, MJ Hobart, PJ Lachmann","International Journal of Immunogenetics 5 (4), 279-282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15721931421411299028,4,1978
Factor B on lymphoid cells,"L Halbwachs, PJ Lachmann, I McConnell","The Journal of Immunology 116 (6), 1735-1735",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10871325465127266432,4,1976
The demonstration on lymphocytes of an activity resembling factor B of the alternative pathway of complement activation,"L Halbwachs, I McConnell, PJ Lachmann",International Symposium on Membrane Receptors of Lymphocytes,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3803360087196425013,4,1975
A novel and sensitive functional assay for complement Factor I based on the third proteolytic clip of C3b,"PJ Lachmann, E Lay, DJ Seilly","Journal of immunological methods 457, 30-32",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8535511241300182102,3,2018
"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK","C Pritchard, T Hickish","World Health 26, 2214-28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4895871247922776244,3,2011
The complement system in renal diseases,"M Macanovic, P Lachmann","Complement and kidney disease, 1-18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8390434621484819762,3,2006
The risk to the United Kingdom population of zinc cadmium sulfide dispersion by the Ministry of Defence during the “cold war”,"PJ Elliott, CJC Phillips, B Clayton, PJ Lachmann","Occupational and environmental medicine 59 (1), 13-17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9260568136163678654,3,2002
Diet and Diseases: Facts and Fantasies,PJ Lachmann,"UK Academy of Medical Sciences, available at www. acmedsci. ac. uk/n diet. htm",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8977635176218368842,3,1999
"Recombinant human DNase I (rhDNase) for SLE nephritis: Characterization of safety, tolerance & disposition following systemic administration.","VG Hale, JV Braun, L Richardson, V Pacheco, D Sinicropi, WS Prince, ...","ARTHRITIS AND RHEUMATISM 39 (9), 1356-1356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9687118648353262680,3,1996
Current topics in complement research.,PJ Lachmann,"Research in immunology 147 (2), 69-70",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12078142275494422248,3,1996
"Euthanasia: death, dying, and the medical duty","GR Dunstan, PJ Lachmann","British medical bulletin 52 (2), 229-399",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=805145206624842463,3,1996
Structure and gross arrangement of the C6 and C7 genes,"MJ Hobart, B Fcrnie, RG DiScipio, PJ Lachmann","Molecular Immunology 30, 16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18195576957804599189,3,1993
Molecular basis of combined C6 and C7 deficiency: C6,"MJ Hobart, BA Fernie, R Würzner, BP Morgan, PJ Lachmann","Molecular Immunology 30, 16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12563087056149470663,3,1993
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate.,"AM Montgomery, MG Wing, PJ Lachmann","Immunology 75 (2), 217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13129192531202646226,3,1992
Peptide inhibitors of C3 breakdown,"P Peake, M Szelke, DM Jones, A Singleton, J SUEIRAS‐DIAZ, ...","Clinical & Experimental Immunology 79 (3), 454-458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9481510163680818260,3,1990
Biochemistry and genetics of complement,"RR Porter, PJ Lachmann, KBM Reid",The Royal Society,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17017464148601864127,3,1984
Intestinal glycoprotein activates the alternative complement pathway by reacting with factor H,"R Winsnes, PJ Lachmann","Scandinavian journal of immunology 15 (4), 371-378",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3908524569249773488,3,1982
Immunological aspects of skin diseases,I Gigli,"Clinical aspects of immunology, 4th edn. Blackwell, Oxford, 790-821",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12217749352324070306,3,1982
Clínica inmunológica,"PGH Gell, RRA Coombs, PJ Lachmann, JF Ackroyd",Salvat,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16838262973746352740,3,1980
Genetic defects of complement in man,"PJ Lachmann, FS Rosen","Immune deficiency, 105-119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13220740862411717037,3,1979
Complement deficiencies,PJ Lachmann,"British Journal of Dermatology 92 (5), 593-594",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7955204241440951355,3,1975
Subtyping Haptoglobins with Precipitating Antisera,C Ehnholm,"International Archives of Allergy and Immunology 36 (5), 427-441",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5830998560195329181,3,1969
"Evolution, ethics and religion",PJ Lachmann,"Global Bioethics 25 (3), 156-163",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1182977164283462268,2,2014
God: The failed hypothesis. how science shows that god does not exist,PJ Lachmann,"American Journal of Psychology 122 (2), 272-278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6998626130594285609,2,2009
Microbial Subversion of Immunity: Current Topics,"PJ Lachmann, MBA Oldstone",Horizon Scientific Press,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15667272544084720991,2,2006
Stem cell therapy: medical advance or moral challenge?,PJ Lachmann,"Comptes rendus biologies 325 (10), 1049-1051",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5352023396773760751,2,2002
Derivatization of soluble human CD59 with a myristoylated peptide creates a potent membrane-bound inhibitor of complement-mediated lysis,"GP Smith, I Dodd, A Davies, BP Morgan, PJ Lachmann, RAG Smith","Immunopharmacology 1 (49), 53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13935695201498686967,2,2000
"Complement, alternative pathway",PJ Lachmann,Elsevier,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4004641615887494842,2,1998
"Euthanasia: Death, dying and the medical duty-Preface","GR Dunstan, PJ Lachmann","BRITISH MEDICAL BULLETIN 52 (2), 229-230",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15204353514952840296,2,1996
Blake and the Idea of the Book,S Symmons,"The British Journal of Aesthetics 35 (3), 308-310","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12204103445743534311,606004182112395204",2,1995
A novel human complement component C7 phenotype detected in South Africa and proposed designation of the allele as C7* 10,"A Orren, R Würzner, PJ Lachmann, MJ Hobart","International Journal of Immunogenetics 21 (3), 181-187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2050811266771925275,2,1994
The C7 M/N polymorphism is determined by a neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15,"R Würzner, BA Fernie, MJ Hobart, A Orren, PJ Lachmann","Molecular Immunology 30, 63",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=30348269556540066,2,1993
Determination of the solution structure of CD59 by 2D-NMR confirms the predicted similarity of folding topology between it and snake venom neurotoxins,"CM Fletcher, RA Harrison, PJ Lachmann, D Neuhaus","Molecular Immunology 30, 10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14806616035202309317,2,1993
A cleavable biotinylating agent and its use in protein electroblots,"MJ Hobart, BA Fernie, PJ Lachmann","Journal of immunological methods 153 (1-2), 93-98",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4416430371166320865,2,1992
Antibody engineering: current status and future development,"S Songslvllai, PJ Lachmann","Asian Pacific journal of allergy and immunology 8 (1), 53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1909460649531965650,2,1990
SELECTIVE ACTIVATION OF NEUTROPHIL COMPLEMENT RECEPTOR TYPE-3 (CR3) BY ZYMOSAN,"GD Ross, JA Cain, CJ Davies, PJ Lachmann","FEDERATION PROCEEDINGS 44 (6), 1861-1861",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11147703943491068274,2,1985
NEW GENETIC COMPLEMENT DEFICIENCY,"PJ Lachmann, MJ Hobart","PATHOLOGIE BIOLOGIE 25 (6), 398-398",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=582354569054395660,2,1977
Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway.,"A Martin, PJ Lachmann","Clinical and experimental immunology 27 (1), 13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18091194762341797458,2,1977
Systemic Lupus Erythematosus: Experimental Aspects of Systemic Lupus Erythematosus,PJ Lachmann,"Proceedings of the Royal Society of Medicine 60 (5), 464-465",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4368575052534806289,2,1967
Stabilization by Vi polysaccharide of the red-cell-linked antigen—antiglobulin complex allowing identification of the Ig—type of the combined antibodies by means of specific …,"RRA Coombs, WE Jonas, PJ Lachmann","Immunology 10 (5), 493",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17439402028680269908,2,1966
Clínica inmunológica,"PGH Gell, RRA Coombs, PJ Lachmann",Salvat,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8007829396462366109,2,1965
MODULATION OF IMMUNE RESPONSES THROUGH COMPLEMENT DOWNREGULATION USING ADENO-ASSOCIATED VIRUS MEDIATED GENE THERAPY,"A Ahmad, GJ Logan, A Buchberger, S Tay, PJ Lachmann, IE Alexander",JOURNAL OF GENE MEDICINE 20 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14399309583070414107,1,2018
"Speaking ill of Darwin and Chomsky: Little Brown & Co., New York, 2016",P Lachmann,"The FASEB Journal 31 (2), 434-435",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15767888073217149430,1,2017
Treatment of diseases related to hyperactivity of the complement system,P Lachmann,"US Patent 9,066,941","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4526277364314993894,12650594689841136323",1,2015
A more radical solution,P J Lachmann,"Reviews on recent clinical trials 10 (1), 25-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5926535627503505405,1,2015
Editorial (Thematic Issue: The Urgent Need to Reform the Present System of Medicines’ Regulation),P J Lachmann,"Reviews on recent clinical trials 10 (1), 2-4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10667124803122171511,1,2015
Traditional passive immune therapy for emerging Ebola infection,PJ Lachmann,"Emerging microbes & infections 3 (11), e81",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1631855731884632013,1,2014
Health care: Better drug access for terminal patients,"DA Brindley, RW Barker, PJ Lachmann","Nature 502 (7469), 38",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14523988005818669232,1,2013
Ethics evolve,P Lachmann,"European Review 21 (S1), S109-S113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=793259648872293293,1,2013
An open letter to the health secretary: how to really save money on the NHS,P Lachmann,"BMJ 341, c5618",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1629370333628875861,1,2010
Robert Royston Amos (Robin) Coombs. 9 January 1921—25 January 2006,"P Lachmann, H Waldmann","Biographical Memoirs of Fellows of the Royal Society, 45-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15991726990027408607,1,2009
Genetic deﬁciencies of the complement system,PJ Lachmann,"Ontogeny of Acquired Immunity 5, 193",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14677119653776900189,1,2009
Microbial Subversion of NK Cell Function,"UH Koszinowski, S Jonjic","Microbial Subversion of Immunity: Current Topics, 117",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12677596903274552962,1,2006
Subversion of the immune response by helminths,MJ Doenhoff,"Microbial Subversion of Immunity: Current Topics, 107-176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13006761779069154726,1,2006
The membrane attack complex inhibitor of streptococcus pyogenes (SIC) binds preferentially to C567,"BA Fernie-King, DJ Seilly, A Davies, PJ Lachmann","Immunopharmacology 1 (49), 74",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16620484598615030669,1,2000
An analysis of the IgE and IgG response to wasp venom antigens before and after venom immunotherapy,"PW Ewan, J Deighton, PJ Lachmann","CLINICAL AND EXPERIMENTAL ALLERGY 24 (2), 171-171",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16318444113031587567,1,1994
IL-6 DOMINATES THE TH-2 CYTOKINE RESPONSE BY PBMC IN ATOPIC PATIENTS,"SM McHugh, AB Wilson, J Deighton, PJ Lachmann, PW Ewan","CLINICAL AND EXPERIMENTAL ALLERGY 24 (2), 187-187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6064802786670001784,1,1994
Cd-59-like molecule in trypanosoma cruzi,"DV Tambourgi, VPL Ferriani, PJ Lachmann, M Giusti, WD Silva, TL Kipnis, ...","Clinical and Experimental Immunology 97 (suppl. 2), 46","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5068434047748131120,1257697974729831497",1,1994
The use of purified protein derivative of tuberculin (PPD) as a carrier molecule for immunization particularly with peptides,PJ Lachmann,"TalwarGP, RaoKVS, ChauhanVS, editors. Recombinant and synthetic vaccines …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9896338412958999427,1,1994
The dysmorphic but functionally active C6 of subtotal C6 deficient subjects is carboxyterminally truncated,"R Würzner, D Mewar, PJ Lachmann","Molecular Immunology 30, 63",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8988206170349377427,1,1993
Soluble CD59 is present in human plasma,"WD Ramoff, MC McCord, S Meri, N Okada, PJ Lachmann","Molecular Immunology 30, 46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8941412766074842837,1,1993
The Seventh K Prathap Memorial Lecture. The pathogenesis of autoimmune immune complex disease.,PJ Lachmann,"The Malaysian journal of pathology 14 (1), 1-5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3669290536016436589,1,1992
Cytolysis by Cloned Helper T Cells: Induction by Specific Antigen or by Anti‐CD3 Hybrid Antibodies,"A Vyakarnam, AL Strangeways, RE Glover, PJ Lachmann","Scandinavian journal of immunology 27 (6), 635-644",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18086391139287032596,1,1988
Does complement play a role in mucosal immunity?,PJ Lachmann,"Monographs in allergy 24, 121",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5226703118216745155,1,1988
Murine and human tuberculin reactive T helper clones: their role in anti-tumour immunity,"A Vyakarnam, DY Sia, PJ Lachmann","Human T Cell Clones, 435-450",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8567590695512545634,1,1985
Genetics of complement,"PJ Lachmann, MJ Hobart","Trends in Genetics 1, 145-150",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1665480902770209164,1,1985
CONSUMPTION OF ERYTHROCYTE (E) CR-1 (C3B-RECEPTOR) IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND OTHER DISEASES INVOLVING AUTOANTIBODIES AND COMPLEMENT (C) ACTIVATION,"GD Ross, MJ WALPORT, CJ Parker, AF Lentine, CR Fuller, WJ Yount, ...","CLINICAL RESEARCH 32 (2), A539-A539",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13202498331629043538,1,1984
RHEUMATOID SYNOVITIS-A LOCALIZED FORM OF ANGIONEUROTIC-EDEMA,"P Woo, C Cooper, R Harrison, N AMOS, J Reeve, P LACHMANN",ANNALS OF THE RHEUMATIC DISEASES 43 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5784246791263035470,1,1984
COMPARISON OF LEUKOCYTE MEMBRANE C-RECEPTOR TYPE-3 (CR3) AND BOVINE SERUM CONGLUTININ (K),"GD Ross, PJ Lachmann","Immunobiology 164 (3-4), 290-291",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7823232533414997234,1,1983
Inhibition of alternative pathway convertase by rat monoclonal antibodies to human factor B,"S Ruddy, PJ Lachmann","Molecular Immunology 19 (11), 1399",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10602325195054501841,1,1982
"The breakdown of C3bi to C3c, c3d and C3g",PJ Lachmann,"Molecular Immunology 19 (11), 1382",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5914210826713896468,1,1982
immunology todny,"JF Bach, R van Furth, CS Henney, K James, CA JanewayJr, DH Katz, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12389930170258701467,1,1981
MONOCLONAL-ANTIBODIES TO HUMAN C-3,"PJ Lachmann, RG Oldroyd, B Wright, C Milstein","JOURNAL OF IMMUNOLOGY 124 (3), 1527-1527",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17896077171856620026,1,1980
The Capacity of Lymphoblastoid Cells to Activate the Alternative Complement Pathway Is Correlated with their Transformation by Epstein-Barr Virus,"I Mc-Connell, PJ Lachmann, T Lint, G Klein","The Journal of Immunology 120 (5), 1787-1787",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=25373343983092273,1,1978
The use of bovine conglulinin as a reagent for detecting immune complexes,"PJ Lachmann, M Macanovic, G Harkiss, DL Brown","Protides of Bialagical Fluids, 26th Colloquium. Pergamon, Oxford",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11817653165841963191,1,1978
Immunology of the Gut,"PJ Lachmann, S Ahlstedt, NF Pierce","ELSEVIER, AMSTERDAM",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7165296413718813091,1,1977
Activation of Complement (C) in Human or Animal Serum by Lymphoblastoid Cell Lines Derived from Patients with Burkitt's Lymphoma (BL) and Infectious Mononucleosis (IM),"DB Budzko, PJ Lachmann, I McConnell","The Journal of Immunology 116 (6), 1729-1730",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11034040229969814243,1,1976
Metabolism of C3 and Glycine-Rich β Glycoprotein (GBG) in Hypocomplementaemia,"DK Peters, JA Charlesworth, DG Williams, JGP Sissons, PJ Lachmann","Clinical Science 46 (2), 17P-17P",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2423924486914582418,1,1974
Mechanisms of C3 Breakdown by Hypocomplementaemic Serum from Patients with Mesangiocapillary Nephritis,"DK Peters, J CHARLESWORTH, PJ Lachmann, DG Williams","Protides of the Biological Fluids, 435-440",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6879741701954632569,1,1974
Massive C Activation: The Interactions of C and the Extrinsic Blood Coagulation System in the Production of Disseminated Intravascular Coagulation,"DL Brown, PJ Lachmann","The Journal of Immunology 111 (1), 298-299",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7438283092709484258,1,1973
The Temporary Sequestration of C3-Coated Red Cells (EC43) in the RES of the Rabbit: A Mechanism for the Non-Lytic Damage of Red Cells by Complement,"DL Brown, PJ Lachmann","The Reticuloendothelial System and Immune Phenomena, 111-118",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13059138934470165205,1,1971
Internationales Komplement Symposion 14. und 15. Juli 1969 in Mainz,"H Jacot-Guillarmod, W Opferkuch, M Loos, JA Jensen, R Ringelmann, ...","Medical Microbiology and Immunology 155 (2), 93-109",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7849914470752409517,1,1969
Use of the red cell-linked antigen-antiglobulin reaction to determine the immunoglobulin type of incomplete antibodies to soluble antigens,"RRA Coombs, A Feinstein, WE Jonas, PJ Lachmann","Symp. Ser. Immunobiol. Stand 4, 147-158",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2477460506677698644,1,1967
Blackwell Scientific Publications,"PJ Lachmann, DK Peters",Official journal of the British Society frr Immunology 4 (2),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17973991195893422594,1,0
Systemic ß adrenergic stimulation/sympathetic nerve system stimulation influences intraocular RAS through cAMP in the RPE,"JR Martins, N Reichhart, N Kociok, J Stindl, R Foeckler, P Lachmann, ...","Experimental eye research 189, 107828",,0,2019
Renin cells with defective Gsα/cAMP signaling contribute to renal endothelial damage,"A Steglich, F Kessel, L Hickmann, M Gerlach, P Lachmann, F Gembardt, ...","Pflügers Archiv-European Journal of Physiology 471 (9), 1205-1217",,0,2019
The story of complement factor I,PJ Lachmann,Immunobiology,,0,2019
The Two Cultures at Cambridge,P Lachmann,"European Review 27 (1), 46-53",,0,2019
Reduced activity of the complement system through elevation of complement factor I using AAV mediated gene delivery to the liver,"A Ahmad, GJ Logan, A Buchberger, S Tay, PJ Lachmann, IE Alexander","HUMAN GENE THERAPY 29 (12), A67-A67",,0,2018
Treatment of diseases related to hyperactivity of the complement system,P Lachmann,"US Patent App. 15/720,933",,0,2018
John Gordon-A greatly undervalued complement pioneer.,PJ Lachmann,"Immunobiology 223 (8-9), 524-525",,0,2018
The PPAR-gamma-binding sequence Pal3 is necessary for basal but dispensable for high-fat diet regulated human renin expression in the kidney,"P Lachmann, J Selbmann, L Hickmann, B Hohenstein, C Hugo, ...","Pflügers Archiv-European Journal of Physiology 469 (10), 1349-1357",,0,2017
A teenager with primary pneumococcal peritonitis,"S Ugrinovic, E Gkrania-Klotsas, H Baxendale, H Firth, N Pritchard, ...","Molecular Immunology 89, 156",,0,2017
Medicine Development Needs Radical Reform: Commentary,PJ Lachmann,"J Clin Trials 7 (320), 2167-0870.1000320",,0,2017
Special Issue Complement: Driver of inflammation and therapeutic target in diverse diseases,"BP Morgan, PJ Lachmann","IMMUNOBIOLOGY 221 (6), 699-700",,0,2016
Kidney phenotype of mice with VEGF deficiency in renin-producing cells: P07–03,"N Jetschin, A Steglich, P Lachmann, L Hickmann, B Hohenstein, C Hugo, ...","Acta Physiologica 216, 123-124",,0,2016
Analyse von transgenen Maus-Modellen für die Charakterisierung der Regulationsmechanismen der Reninproduktion und der Funktion der Reninzellen: Rolle der Pal3-Sequenz bei der …,P Lachmann,"Technische Universität Dresden, Medizinische Fakultät",,0,2016
Detection of the neogenesis of renin cells throughout life: P237,"L Hickmann, J Sradnick, C Starke, P Lachmann, A Lüdemann, ...",Acta Physiologica 213,,0,2015
Kidney phenotype of mice with induced deletion of renin in juxtaglomerular cells: P306,"P Lachmann, L Hickmann, SM Gast, B Hohenstein, C Hugo, V Todorov, ...",Acta Physiologica 213,,0,2015
Genetic Deﬁciency Diseases of the Complement System,"PJ LACHMANN, MJ WALPORT",Immunobiology of the Complement System: An Introduction for Research and …,,0,2014
Glomerular injury and thrombotic microangiopathy in mice with impaired Gs-alpha/cAMP signaling in renin cells-possible role of VEGF: P287,P Lachmann,"Acta Physiologica 210, 191-192",,0,2014
PPARgamma-dependent Regulation of Renin-Expression in humanized Mice,"J Selbmann, P Lachmann, L Hickmann, B Hohenstein, C Hugo, ...","INTERNIST 54, 109-109",,0,2013
Renin gene expression is regulated by Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TF II),"P Lachmann, S Mayer, M Roeser, S Ishii, JM Suh, S Harlander, M Desch, ...","The FASEB Journal 27 (1_supplement), 1165.12-1165.12",,0,2013
A novel C3 fragment found in normal plasma and serum: Its implications for C3 tickover,"A Buchberger, D Seilly, P Lachmann","Molecular Immunology 3 (56), 242",,0,2013
Personal View An open letter to the health secretary: how to really save money on the NHS,P Lachmann,BRITISH MEDICAL JOURNAL 341,,0,2010
"GOD:"" TO BE OR NOT TO BE; THAT IS NOT THE QUESTION""",PJ Lachmann,"The American Journal of Psychology 122 (2), 272-278",,0,2009
Marking the 50th Anniversary of the British Society for Immunology,"L Brent, I Cohen, P Doherty, M Feldmann, P Matzinger, S Holgate, ...","Clinical and Experimental Immunology 147 (1), 1-10",,0,2007
The roche rheumatology prize lecture. Complement deficiency and disease.,"M Asgharzadeh, HS Kafil, M Asgharzadeh, A Mazloumi, HS Kafil, ...","Biotechnology 13 (5), 1850-1854",,0,2007
BOOK REVIEW-//Microbial Subversion of Immunity,"PJ Lachmann, MBA Oldstone, CRM Bangham","Clinical Infectious Diseases 44 (1), 157",,0,2007
Functional characterization of DRS from Streptococcus pyogenes M12 and M55 serotypes,"MJ Binks, BA Fernie-King, DJ Seilly, PJ Lachmann, KS Sriprakash","International Congress Series 1289, 219-222",,0,2006
Mapping of functional domains of streptococcal inhibitor of complement (SIC),"MJ Binks, BA Fernie-King, DJ Seilly, PJ Lachmann, KS Sriprakash","International Congress Series 1289, 216-218",,0,2006
Subversion of Complement,R Wurzner,"Microbial Subversion of Immunity: Current Topics, 11",,0,2006
Viral Subversion of Humoral Immune Responses,"M Law, PP Sanna, DR Burton",Microbial Subversion of Immunity: Current Topics,,0,2006
Viruses and Dendritic Cells: A Prominent Mechanism for Subverting the Immune Response,"EI Zuniga, KH Edelmann, MBA Oldstone",Microbial Subversion of Immunity: Current Topics,,0,2006
Evasion Mechanisms of Bacteria,MM Frank,"Microbial Subversion of Immunity: Current Topics, 1095",,0,2006
Viral Immune Evasion: An Overview,A Alcami,"Microbial Subversion of Immunity: Current Topics, 1071",,0,2006
Les défis de la microbiologie et des maladies infectieuses,"N Le Douarin, C Bangham, JL Binet, A Capron, P Cossart, A Fischer, ...",,,0,2005
Gordon Ross-Obituary,P Lachmann,"IMMUNOBIOLOGY 209 (9), 699-700",,0,2005
Interaction of streptococcal inhibitor of complement and its proteolytic fragments with the human b-defensins and secretory leukocyte proteinase inhibitor,"P Lachmann, B Fernie-King, D Seilly",Molecular Immunology 41 (2),,0,2004
Henry Kunkel,P Lachmann,"Lupus 12 (3), 200",,0,2003
CELLULAR MICROBIOLOGY: PATHOGEN-HOST CELL MOLECULAR INTERACTIONS-Streptococcal Inhibitor of Complement Inhibits Two Additional Components of the Mucosal Innate Immune System …,"BA Fernie-King, DJ Seilly, A Davies, PJ Lachmann","Infection and Immunity 70 (9), 4908-4916",,0,2002
"Abstracts of the 8th European Meeting on Complement in Human Disease, 8-12th September 2001, Strasbourg, France-Preface","Z Fishelson, P Lachmann","MOLECULAR IMMUNOLOGY 38 (2-3), 75-75",,0,2001
Hereditary angioedema responding to plasma but not to commercially available C1-inhibitor,"PJ Lachmann, PW Ewan, RA Harrison, EP Wraight","MOLECULAR IMMUNOLOGY 38 (2-3), 104-105",,0,2001
Towards a CD59-based therapeutic: GPI anchor substitution with a membrane-targeting address,"PJE Rowling, J White, L Mansfield, M Steward, JR Bright, PJ Lachmann, ...","MOLECULAR IMMUNOLOGY 38 (2-3), 119-120",,0,2001
"Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis-VIII Conclusions","MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport","Advances in Immunology 2001 (76), 298-298",,0,2000
"Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis-V Lupus Causes Autoantibody Production to C1q","MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport","Advances in Immunology 2001 (76), 281-282",,0,2000
Interaction between complement and the malaria parasite in the mosquito vector,"G Margos, GA Butcher, A Davies, RE Sinden, PJ Lachmann","Immunopharmacology 1 (49), 73",,0,2000
"Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis-IV Complement and Inflammation in SLE","MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport","Advances in Immunology 2001 (76), 279-280",,0,2000
"Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis-VII What Lessons Can Be Learned from Other Murine Models of Autoimmunity?","MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport","Advances in Immunology 2001 (76), 297-297",,0,2000
"Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis-VI Hypotheses for the Association between Complement Deficiency and SLE","MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport","Advances in Immunology 2001 (76), 283-296",,0,2000
"Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis-III Animal Models of Complement Deficiency","MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport","Advances in Immunology 2001 (76), 277-278",,0,2000
"THE PATHOGENESIS OF SLE: THE ROLES OF ANTIGEN, ANTIBODY AND COMPLEMENT","P Lachmann, M Walport",Scandinavian Journal of Immunology 50 (1),,0,1999
Britain's Academy of Medical Sciences has been busy in recent months,P Lachmann,"Bmj 318 (7198), 1624",,0,1999
GM FOOD DEBATE. AUTHORS'REPLY,"A MOWAT, AJ FITZGERALD, RA GOODLAD, NA WRIGHT, P LACHMANN, ...","Lancet 354 (9191), 1725-1729",,0,1999
Association of rs172378 C1q gene cluster polymorphism with lupus nephritis in Bulgarian patients.,"FI Irshaid, DJ Birmingham, JS Navratil, LC Korb, JM Ahearn, PS Ramos, ...","Pakistan Journal of Biological Sciences 21 (3), 47-52",,0,1999
"The Lloyd Roberts Lecture. Immunopathology: past, present and future.",PJ Lachmann,"Transactions of the Medical Society of London 116, 18-30",,0,1999
Allergy and Allergic Diseases,P Lachmann,"Clinical and Experimental Allergy 28 (11), 1444-1445",,0,1998
Down-regulation of T-cell and non-T-cell derived tumor necrosis factor alpha by thalidomide and dexamethasone,"TL Rowland, SM McHugh, PW Ewan, PJ Lachmann, RJ Dearman, ...","FASEB JOURNAL 12 (4), A262-A262",,0,1998
Neutrophyl responses induced by complement-IgA immunocomplexes,"YM Lucisano-Valim, Z Wei, PJ Lachmann",,,0,1998
Immunoconglutinins,PJ Lachmann,Elsevier,,0,1998
CD59,"A Davies, P Lachmann",Elsevier,,0,1998
Structural and functional features of herpesvirus saimiri CD59,"JC Bramley, PJ Lachmann, A Davies","Molecular Immunology 6 (35), 340",,0,1998
Interactions between complement and the malaria parasite in the mosquito gut,"S Navarrete, GA Butcher, G Margos, A Davies, C Willers, PJ Lachmann, ...","Molecular Immunology 6 (35), 340",,0,1998
"Considering that the aim to develop a creative and independent academic pro-fessional role was not mentioned as a reason for the choice of profession, a major implication at …","GR Dunstan, PJ Lachmann",Nursing Ethics 4 (1),,0,1997
HERPESVIRUS SAIMIRI CD59-BACULOVIRUS EXPRESSION AND CHARACTERISATION OF COMPLEMENT INHIBITORY ACTIVITY: Ee360,"JC Bramley, A Davies, P Lachmann",Immunology-Supplement 89,,0,1996
COMPLEMENT IN IgA INDUCED NEUTROPHIL ACTIVATION WEI ZHANG,"Y LUCISANO, P LACHMANN",Immunology-Supplement 89,,0,1996
Herpesvirus saimiri CD59-Baculovirus expression and characterisation of complement inhibitory activity,"JC Bramley, A Davies, P Lachmann",Immunology-Supplement 89,,0,1996
Complement in IgA induced neutrophil activation,"W Zhang, YM Lucisano, PJ Lachmann","IMMUNOLOGY 89, SCC93-SCC93",,0,1996
"Euthanasia: death, dying and the medical duty","JJMV Delden, GR Dunstan, PJ Lachmann","BMJ-British Medical Journal-International Edition 313 (7070), 1494",,0,1996
CD4-INDEPENDENT ENTRY OF LYMPHOCYTOTROPIC STRAINS OF HIV-1 INTO MACROPHAGES MEDIATED BY ENHANCING ANTIBODIES,"H TRISCHMANN, D DAVIS, PJ LACHMANN","JOURNAL OF CELLULAR BIOCHEMISTRY, 247-247",,0,1995
Blackwell I,"MHM RAASVELD, PJ LACHMANN",CLINICAL AND EXPERIMENTAL IMMUNOLOGY 99 (2),,0,1995
Bispecific monoclonal antibodies,"SS AI, PJ LACHMANN","Monoclonal Antibodies, 121",,0,1995
Final discussion,"NA Mitchison, G Trinchieri, DA Cantrell, IA Ramshaw, PJ Lachmann, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 245-250",,0,1995
Cytokines in immune regulation pathogenesis in HIV infection-Discussion,"RM Locksley, GM Shearer, NA Mitchison, TR Mosmann, AK Abbas, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 147-153",,0,1995
General discussion I-Vaccine development,"NA Mitchison, A Sher, G Trinchieri, MT Lotze, RL Coffman, PJ Lachmann, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 35-38",,0,1995
The role of subsets of CD4 (+) T cell autoimmunity-Discussion,"GM Shearer, DW Mason, IA Ramshaw, NA Mitchison, PJ Lachmann, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 182-188",,0,1995
Nitric oxide in infectious and autoimmune diseases-Discussion,"SHE Kaufmann, FY Liew, IA Ramshaw, NA Mitchison, MT Lotze, PM Allen, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 239-244",,0,1995
The development of effector T cell subsets in murine Leishmania major infection-Discussion,"NA Mitchison, RM Locksley, R Flavell, PJ Lachmann, RL Coffman, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 117-122",,0,1995
The two faces of interleukin 12: A pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting-Discussion,"S Romagnani, G Trinchieri, NA Mitchison, RW Dutton, RL Coffman, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 214-220",,0,1995
General discussion III-Allergy,"PJ Lachmann, S Romagnani, NA Mitchison, R Flavell, RW Dutton, ...","T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES 195, 137-141",,0,1995
Evolution of Mutation Rate and Virulence among Human Retroviruses: Discussion,"CA Mims, PW Ewald, PJ Lachmann, AL Hughes, JD Gillett, CE Parker","Philosophical Transactions of the Royal Society of London Series B 346, 341-343",,0,1994
"C6 HAPLOTYPES-ASSOCIATIONS OF A DDE-I SITE POLYMORPHISM TO COMPLEMENT DEFICIENCY GENES AND THE MSP-I RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM (RFLP)(VOL 95, PG 351, 1994)","BA FERNIE, MJ HOBART, G DELBRIDGE, PC POTTER, A ORREN, ...","CLINICAL AND EXPERIMENTAL IMMUNOLOGY 98 (1), 174-174",,0,1994
WESTERN BLOTTING REVEALS THE DIVERSITY OF IGE AND IGG RESPONSES TO BEE VENOM ANTIGENS,"J Deighton, PJ Lachmann, PW Ewan","CLINICAL AND EXPERIMENTAL ALLERGY 24 (2), 170-170",,0,1994
PBMC OF BEE VENOM ALLERGIC PATIENTS PRODUCE HIGH-LEVELS OF IL-4 TO A VENOM EXTRACT IN-VITRO,"SM MCHUGH, AB WILSON, PJ LACHMANN, PW EWAN","CLINICAL AND EXPERIMENTAL ALLERGY 24 (2), 171-171",,0,1994
Identificacao imunoquimica de cd-59 simile em formas infectantes de trypanosoma cruzi,"DV Tambourgi, AL Giusti, E Barbosa, PJ Lachmann, WD Silva, TL Kipnis",Programa e Resumos,,0,1994
Effects of c9 concentration on the restriction presented by sheep red cells to lysis by horse complement,"PAI Assis, G Pereira, RA Harrison, PJ Lachmann",Resumos,,0,1994
"Proceedings of the 5th European Meeting on Complement in Human Disease: Les Diablerets, Switzerland, 9-12 September 1994","European Meeting on Complement in Human Disease (5, 1994, Les Diablerets)",Blackwell,,0,1994
The biology of complement. Introduction.,PJ Lachmann,"Springer seminars in immunopathology 15 (4), 303-306",,0,1994
Proceedings of the 5th European Meeting on Complement in Human Disease,"RA Thompson, PJ Lachmann",CLINICAL AND EXPERIMENTAL IMMUNOLOGY 97,,0,1994
The majority of human C7 synthesised in vivo is of extrahepatic origin,"R Würzner, H Morgan, V Joysey, PJ Lachmann","Molecular Immunology 30, 63",,0,1993
Molecular basis of C6 A/B polymorphism and application to c6 deficiency,"BA Fernie, G Delbridge, MJ Hobart, A Orrcn, P Potter, BP Morgan, ...","Molecular Immunology 30, 10",,0,1993
The evolution of the terminal complement components,"MJ Hobart, B Fcrnie, RG DiScipio, PJ Lachmann","Molecular Immunology 30, 16",,0,1993
"Effect of antibody isotype on the effector functions of human neutrophils, using chemiric anti-nip antibodies","YM Lucisano-Valim, A Azzolini, ACM Polizello, PJ Lachmann",Resumos,,0,1993
Deposition of terminal complement complex (tcc) is associated with the presence of a cr1 receptor fragment (cr1 s-stump) in glomeruli of patients with proliferative empus nephritis,"JE Teixeira, RS Costa, PJ Lachmann, R Wizner, JE Barbosa","Molic Immunology 80, 55",,0,1993
Deteccao de um fragmento do receptor cr1 de prodocitos em lomerulorefrite proliferativa do lupus eritematoso sistemico,"JE Barbosa, RS Costa, P Lachmann, JE Teixeira",Resumos,,0,1992
Detection of a fragment ot the cr1 receptor on podolytes of sle proliferative glomerulonephritis,"JE Barbosa, RS Costa, P Lachmann, JE Teixeira","Immunobiology 184 (4-5), 412",,0,1992
Complement mediated solubilization of human. Mause chimaeric antibodies of different isotypes immune precipitates,"YM Lucisano-Valim, PJ Lachmann",Resumos,,0,1992
Antibody isotypes pathern of complement activation depends on antigenic epitope density and antigen antibody ratio,"YM Lucisano-Valim, PJ Lachmann","Complement and Inflammation 8 (3-4), r-290",,0,1991
Effect of antibody isotype in the complement activation induced by preformed and nascent imune complexes,"YM Lucisano-Valim, PJ Lachmann","Arquivo de Biologia e Tecnologia 20 (1), 169",,0,1991
The interaction between rat olicodendrocytes and human complement in vitro,"JP Zajicek, MW Wing, PJ Lachmann, DAS Compston","Journal of Neuroimmunology 35, 111",,0,1991
"THE MECHANISM OF ACTION OF PROTECTIN (CD59), A HOMOLOGOUS RESTRICTION FACTOR OF THE HUMAN-COMPLEMENT SYSTEM","S MERI, B MORGAN, A DAVIES, R DANIELS, M OLAVESEN, ...",SCANDINAVIAN JOURNAL OF IMMUNOLOGY 32 (4),,0,1990
CHIMERIC HUMAN MOUSE BISPECIFIC MONOCLONAL-ANTIBODIES,"S SONGSIVILAI, PM CLISSOLD, PJ LACHMANN","BRITISH JOURNAL OF CANCER 62 (3), 486-486",,0,1990
Molecular genetics of muscle disease--Duchenne and other dystrophies. Future prospects.,PJ Lachmann,"British medical bulletin 45 (3), 819-824",,0,1989
Analise da restricao a lise de hemacias de carneiro por complemento equino,"AI Assis, G Pereira, JE Barbosa, A Azzolini, RH Harrison, PJ Lachmann",Resumos,,0,1989
It is increased carriage on red cell c'R IND. 1'and not solubilization that is the main function of complement in the handling of immunocomplexes,"JE Barbosa, P Gatenby, T Okuda, PJ Lachmann","Complement and Inflammation 6 (5), 310",,0,1989
Efeito de anticorpos monovalentes (fab/c) na formacao e transporte de imunocomplexos in vitro,"JE Barbosa, W Emlen, DL Brown, PJ Lachmann",Resumos,,0,1989
CLINICAL AND EXPERIMENTAL,"RA THOMPSON, PJ LACHMANN",,,0,1989
Effect of specific monovalent (fab/c) antibodies on the formation and handling of immune complexes in vitro,"JE Barbosa, W Emlen, DL Brown, PJ Lachmann","Complement 5, 203",,0,1988
Anti-peptide antibody detecting a neo-antigen on the cri stump left on erythrocytes after proteolysis,"JE Barbosa, RA Harrison, PJ Lachmann","Complement 5, 203-4",,0,1988
R. A. THOMPSON,PJ LACHMANN,,,0,1988
Complement Today,PJ Lachmann,"Scandinavian Journal of Immunology 27 (1), 123-126",,0,1988
"indeed immunoglobulins, and in most cases normal immunoglobulins, opened the way to the study of the human immunoglobulin molecule by chemical, immunological and genetic …",PJ LACHMANN,Clinical Immunology: Proceedings of the 1st IUIS Conference on Clinical …,,0,1987
Analysis of the restriction of lysis of sheep ea by horse serum,"AI Assis, RA Harrison, PJ Lachmann","Complement 4 (3-4), 129",,0,1987
"MITI Unit, MRC Centre, Hills Road, Cambridge, CB2 2QH, UK.",PJ LACHMANN,Clinical immunology: proceedings of the 1st IUIS Conference on Clinical …,,0,1987
THE NATURE OF AUTOIMMUNE-DISEASE-GENERAL DISCUSSION,"H MCDEVITT, A COOKE, N MITCHISON, N ROSE, E NEILSON, I ROITT, ...",CIBA FOUNDATION SYMPOSIA 129,,0,1987
IMMUNOREGULATORY APPROACHES TO TREATMENT-FINAL GENERAL DISCUSSION,"D PETERS, I ROITT, H MCDEVITT, G NOSSAL, P LACHMANN, ...",CIBA FOUNDATION SYMPOSIA 129,,0,1987
ROLE OF EXTERNAL TRIGGERS-FINAL GENERAL DISCUSSION,"H VALDIMARSSON, PJ LACHMANN, IR MACKAY","CIBA FOUNDATION SYMPOSIA 129, 258-&",,0,1987
Recent Advances in Our Knowledge of Complement,PJ Lachmann,"Clinical Chemistry, 699-703",,0,1987
Murine and human tuberculin reactive T helper clones: their,"A Vyakarmam, DY Sia, PJ Lachmann","Human T Cell Clones: A New Approach to Immune Regulation 9, 435",,0,1985
25. Hereditary angio-oedema,PJ Lachmann,"The Urticarias, 194",,0,1985
MONOCLONAL-ANTIBODIES TO THE LYTIC MOLECULE IN LYMPHOCYTE CYTO-TOXICITY,"RHR WARD, PJ LACHMANN","JOURNAL OF LEUKOCYTE BIOLOGY 38 (1), 164-164",,0,1985
HELPER T-CELL CLONES AGAINST PURIFIED PROTEIN DERIVATIVE (PPD) IN THE ENHANCEMENT OF TUMOR-IMMUNITY IN EXPERIMENTAL MICE WHEN IMMUNIZED WITH METHYLCHOLANTHRENE (MCA)-INDUCED …,"DY SIA, PJ LACHMANN","IMMUNOBIOLOGY 167 (1-3), 109-109",,0,1984
COMPLEMENT RECEPTOR TYPE-1 EXPRESSION AND INHERITANCE IN SYSTEMIC LUPUS-ERYTHEMATOSUS,"MJ WALPORT, C MACKWORTHYOUNG, CD ROSS, N HOGG, ...","BRITISH JOURNAL OF RHEUMATOLOGY 23 (2), 123-123",,0,1984
A REVERSIBLE BIOTINYLATING AGENT-USE IN WESTERN BLOTS,"MJ HOBART, BA FERNIE, PJ LACHMANN","GENETICAL RESEARCH 43 (2), 217-217",,0,1984
Why Study Complement Genetics?,P Lachmann,"Recent Advances in Immunology, 77-86",,0,1984
SIMULTANEOUS TURNOVER OF NORMAL AND DYSFUNCTIONAL C1-INA AS A PROBE OF C1 (AND CONTACT-ACTIVATED PROTEASE) ACTIVATION INVIVO,"P WOO, R HARRISON, N AMOS, J Reeve, P LACHMANN",IMMUNOBIOLOGY 164 (3-4),,0,1983
CONGLUTININ IS A COLLAGEN-LIKE PROTEIN,"AE DAVIS, PJ LACHMANN","IMMUNOBIOLOGY 164 (3-4), 231-231",,0,1983
ANTIBODY INDEPENDENT CLASSICAL PATHWAY ACTIVATION BY EBV,"H MARTIN, I MCCONNELL, PJ LACHMANN","IMMUNOBIOLOGY 164 (3-4), 273-274",,0,1983
MW STEWARD,"GL ASHERSON, BA ASKONAS, JM AUSTYN, RW BALDWIN, EB BELL, ...",,,0,1983
Allotyping of monocyte C3,"B Shiels, MJ Hobart, PJ Lachmann","Molecular Immunology 19 (11), 1402",,0,1982
MEMBRANE ATTACK BY COMPLEMENT (WITH COMMENTS ON CELL-MEDIATED CYTO-TOXICITY)-DISCUSSION,"M MAYER, V HU, C HENNEY, W CLARK, P HENKART, E MARTZ, ...","ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 146, 217-225",,0,1982
ENHANCEMENT OF TRANSPLANTATION IMMUNITY TO A SPONTANEOUS MURINE TUMOR,"A VYAKARNAM, PJ LACHMANN, K SIKORA","BRITISH JOURNAL OF CANCER 46 (3), 484-484",,0,1982
THE MOLECULAR-BASIS FOR CYTOLYTIC LYMPHOCYTE-T FUNCTION-ANALYSIS WITH BLOCKING MONOCLONAL-ANTIBODIES-DISCUSSION,"C HENNEY, E MARTZ, R MACDONALD, P LACHMANN, L SIMPSON","ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 146, 467-468",,0,1982
DIRECT ANALYSIS OF INDIVIDUAL KILLER T-CELLS-SUSCEPTIBILITY OF TARGET-CELLS TO LYSIS AND SECRETION OF HYDROLYTIC ENZYMES BY CTL-DISCUSSION,"P LACHMANN, D ZAGURY, P GOLSTEIN, G BERKE, R HERBERMAN, ...","ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 146, 165-169",,0,1982
CELL-SURFACE PROPERTIES INFLUENCING TARGET-CELL SENSITIVITY FOR NK-LYSIS-DISCUSSION,"P GOLSTEIN, R KIESSLING, M MAYER, C HENNEY, R HERBERMAN, ...","ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 146, 375-377",,0,1982
"COMPLEMENT DEFECTS, IMMUNOLOGICAL HEALTH, AND IMMUNOLOGICAL DISEASE",P Lachmann,"Immunopathology: Viiith International Symposium, 1980: Held at San Diego …",,0,1982
COMBINED C2 DEFICIENCY AND HYPOGAMMAGLOBULINEMIA IN A PATIENT WITH LUPUS-LIKE SYNDROME,"P WOO, S PEREIRA, PJ LACHMANN, AM DENMAN","ANNALS OF THE RHEUMATIC DISEASES 40 (5), 519-520",,0,1981
COMPLEMENT ACTIVATION IN LYMPH-NODES INDUCES CELL SHUTDOWN BY A MECHANISM INVOLVING PROSTAGLANDIN SYNTHESIS,"I MCCONNELL, J HOPKINS, JD PEARSON, PJ LACHMANN","JOURNAL OF IMMUNOLOGY 124 (3), 1531-1531",,0,1980
CONGLUTININ TEST FOR THE DETECTION OF IMMUNE-COMPLEXES,"M MACANOVIC, PJ LACHMANN","PERIODICUM BIOLOGORUM 81 (2), 287-288",,0,1979
The Immune Response in Subacute Sclerosing Panencephalitis,"PJ Lachmann, NT Gorman, J Habicht, PW Ewan, G Agnarsdottir, ...","Aspects of Slow and Persistent Virus Infections, 113-130",,0,1979
Effector Mechanisms in Immunopathology,PJ Lachmann,"Immunopathology, 274",,0,1979
Biological Amplification Systems in Immunology: Vol. 2 of Comprehensive Immunology,PJ Lachmann,"Immunology 35 (2), 426",,0,1978
Book Review: The Generation of Antibody Diversity: A New Look,P Lachmann,"Proceedings of the Royal Society of Medicine 70 (4), 294-295",,0,1977
CIBA FOUNDATION SYMPOSIUM (NEW SERIES) 46,"PJ Lachmann, S Ahlstedt, NF Pierce","ELSEVIER, AMSTERDAM",,0,1977
Contributions in Immunology,"HM Grey, LÅ Hanson, M Harboe, PJ Lachmann, HJ Müller‐Eberhard, ...","Scandinavian Journal of Immunology 5 (6‐7), 605-608",,0,1976
Reaction-Mechanisms Of C3NeF,"DK Peters, N Amos, JGP Sissons, PJ Lachmann","The Journal of Immunology 116 (6), 1746-1746",,0,1976
Techniques of Fractionating Complement in-Vivo by the Use of Activated Complement Components to Trigger the C3b Feedback Cycle,"LW Mak, PJ Lachmann, J Majewski","The Journal of Immunology 116 (6), 1741-1741",,0,1976
A Defect of the Alternative Pathway of Complement in Sickle Cell Disease,"W Wilson, GRV Hughes, PJ Lachmann","Clinical Science 50 (2), 12P-12P",,0,1976
Variable region (fv) determinants on mouse lymphocytes.,"PJ Lachmann, D Givol",,,0,1976
IMMUNOCONGLUTININS AND COMPLEMENT IN HUMAN SALIVA,"SJ CHALLACOMBE, BD WILLIAMS, PJ LACHMANN, T LEHNER","JOURNAL OF DENTAL RESEARCH 54, L99-L99",,0,1975
NONALLERGIC LYMPHOCYTE-MEDIATED REACTIONS WITH MEASLES-INFECTED CELLS,"G AGNARSDOTTIR, H VALDIMARSSON, PJ LACHMANN","ARCHIVES OF NEUROLOGY 32 (7), 499-500",,0,1975
25. POLYMORPHISM OF THE SIXTH COMPONENT OF COMPLEMENT,"MJ Hobart, PJ Lachmann","Isoelectric focusing, 306",,0,1975
Genetic Factors in Complement Deficiency,"DL BROWN, PJ LACHMANN",Allergy'74: Proceedings of the Ninth European Congress of Allergology and …,,0,1975
A. Films and Videotapes,"HN Eisen, CR Parish, GL Ada, RA Reisfeld, BD Kahan, BA Askonas, ...",The Journal of Immunology 12 (4),,0,1974
NEW BIOLOGIC ACTIVITY OF COMPLEMENT ASSOCIATED WITH ITS INTRAVASCULAR ACTIVATION AND RELEASE OF A LOW-MOLECULAR WEIGHT FACTOR,"C MCCALL, D BROWN, P LACHMANN, L DECHATELET","JOURNAL OF CLINICAL INVESTIGATION 53 (6), A51-A51",,0,1974
METABOLISM OF THIRD COMPONENT OF COMPLEMENT (C3) AND GLYCINE-RICH BETA GLYCOPROTEIN (GBG) IN PATIENTS WITH MESANGIOCAPILLARY GLOMERULONEPHRITIS AND PARTIAL LIPODYSTROPHY,"CHARLESW. JA, DG WILLIAMS, SHERINGT. E, PJ LACHMANN, ...","AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 4 (4), 432-432",,0,1974
USE OF RADIOACTIVE GOLD TO DETECT ALLERGY TO TUBERCULIN INVITRO,"CJ MEADE, PJ LACHMANN, S BRENNER","THORAX 29 (5), 615-615",,0,1974
Role of C3b in Breakdown of C3 in Hypocomplementaemic Mesangiocapillary Nephritis (MCGN),"DK Peters, DG Williams, J Charlesworth, PJ Lachmann","The Journal of Immunology 111 (1), 295-295",,0,1973
PRELIMINARY COMMUNICATIONS,"PJ Lachmann, MJ Hobart, WP Aston, DK Peters","Medicine 134, 905",,0,1973
C3 ACTIVATION BY HYPOCOMPLEMENTEMIC SERA OF PATIENTS WITH MESANGIOCAPILLARY GLOMERULONEPHRITIS,"D GWYN, CHARLESW. JA, PJ LACHMANN, DK PETERS","EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 3 (3), 234-234",,0,1973
DEFICIENCY OF SECOND COMPONENT OF COMPLEMENT WITH AN ANAPHYLACTOID PURPURA-LIKE RASH,"M SUSSMAN, JH JONES, JD ALMEIDA, PJ LACHMANN","PATHOLOGIA EUROPAEA 8 (1), 78-78",,0,1973
of the complement system,PJ LACHMANN,"Ontogeny of Acquired Immunity: A Ciba Foundation Symposium, 193",,0,1972
"Biological Activities of Complement, pp. 202-214 (Karger, Basel 1972)","PJ Lachmann, DE Elias, A Moffett","Biological activities of complement 5, 202",,0,1972
Complement metabolism in membranoproliferative nephritis.,"DK Peters, A Weinstein, A Martin, JS Cameron, TM Barratt, PJ Lachmann","The Quarterly journal of medicine 40 (160), 568-568",,0,1971
THE TEMPORARY SEQUESTRATION OF C3-C0ATED RED CELLS (ECk3) IN THE RES OF THE RABBIT: A MECHANISM FOR THE NON-LYTIC DAMAGE OF RED CELLS BY COMPLEMENT,"DL Brown, PJ Lachmann",The Reticuloendothelial system and immune phenomena: proceedings of the …,,0,1971
"C1s, C4 and C2 became similarly unreactive with C3-Coombs reagent following incu","N ABRAMSON, CA ALPER, PJ LACHMANN, FS ROSEN","The journal of immunology 107 (1-2), 19",,0,1971
MEASUREMENT OF COMPLEMENT,PJ LACHMANN,"ACTA ALLERGOLOGICA 26 (6), 487-&",,0,1971
MECHANISMS OF COMPLEMENT MEDIATED TISSUE DAMAGE,PJ LACHMANN,"NEPHRON 8 (4), 404-&",,0,1971
COMPLEMENT METABOLISM IN MEMBRANO-PROLIFERATIVE GLOMERULONEPHRITIS,"K PETERS, A WEINSTEIN, A MARTIN, JS CAMERON, TM BARRATT, ...","EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 1 (5), 387-+",,0,1971
Dyscrasias of Immunoglobulin Production: Their Impact on Modern Immunology,PJ Lachmann,"Immunology 19 (1), 186",,0,1970
L. E. GLYNN,"R AUGUSTIN, JR BATCHELOR, I BATTY, JJ BULLEN, A BUSSARD, ...",,,0,1968
COMPLEMENT-DEPENDENT LYSOSOMAL ACTIVATION,"PJ LACHMANN, RRA COOMBS, HB FELL, JT DINGLE","JOURNAL OF IMMUNOLOGY 101 (4), 819-&",,0,1968
"THE REVERSIBLE"" DEDIFFERENTIATION"" OF EMBRYONIC SKELETAL TISSUES IN CULTURE IN RESPONSE TO COMPLEMENT-SUFFICIENT ANTISERUM HONOR B. FELL AND JT DINGLE","RRA COOMBS, PJ LACHMANN","Differentiation and immunology 7, 49",,0,1968
BLACKWELL SCIENTIFIC PUBLICATIONS OXFORD AND EDINBURGH,"R AUGUSTIN, JR BATCHELOR, I BATTY, JJ BULLEN, A BUSSARD, ...",,,0,1967
Fluorescent Protein Tracing: 2nd edn.,GD Johnson,"Immunology 9 (1), 97",,0,1965
Immuno-electrophoretic Analysis,PJ Lachmann,"Immunology 9 (1), 97",,0,1965
"Contents, Vol. 27, 1965","RRA Coombs, WE Jonas, PJ Lachmann, A Feinstein, F Milgrom, ...","International Archives of Allergy and Immunology 27 (6), I-IV",,0,1965
International Symposium on Immunological Tolerance,"RRA Coombs, WE Jonas, PJ Lachmann, A Feinstein, F Milgrom, ...","International Archives of Allergy and Immunology 27 (6), 361-380",,0,1965
Introduction to Electron Microscopy,K Little,"Immunology 6 (2), 204",,0,1963
"The Scientific Basis of Medicine (Annual Reviews, 1962)",PJ Lachmann,"Immunology 6 (2), 204",,0,1963
CHAPTER TEN COMPLEMENT,PJ Lachmann,"Clinical Aspects of Immunology, 246",,0,1963
A ring precipitin test in chronic liver disease: a study of the false positive,"JM Walshe, PJ Lachmann, H Orrego-Matte","Immunology 4 (3), 232",,0,1961
AN ATTEMPT TO CHARACTERIZE ANTIGENIC SPECIFICITY OF LE CELL FACTOR,PJ LACHMANN,"ARTHRITIS AND RHEUMATISM 4 (1), 116-&",,0,1961
ALLERGIC REACTIONS IN RELATION TO BLOOD VESSELS,PJ LACHMANN,"Progress in the Biological Sciences in Relation to Dermatology--2, 403",,0,1960
Aktuelle Probleme der Dermatologie/Current Problems in Dermatology/Problèmes Actuels de Dermatologie,PJ Lachmann,"Immunology 2 (4), 414",,0,1959
PATTERNS OF TH1/TH2 CYTOKINE SECRETION FROM PBMC IN PRIMARY CULTURE AFTER MITOGENIC AND ANTIGENIC STIMULATION,"S McHugh, J Deighton, P Lachmann, P Ewan","Allergy: European Journal of Allergy & Clinical Immunology, Supplement 51, 24-25",,0,0
"Introduction to Electron Microscopy. By SAUL WISCHNITZER. Pergamon Press, Oxford, 1962. Pp. 132, 42s.",PJ LACHMANN,,,0,0
"Immuno-electrophoretic Analysis. Ed. by P. GRABAR and P. BURTIN. Elsevier, Amsterdam",PJ LACHMANN,,,0,0
REFERENCE EDITION Volume 7,"AE Bianco, FEG Cox, PH David, C Frasch, AE Keymer, G Franceville, ...",,,0,0
It’s what not where you publish that matters,"JA Jacobs, PJ Lachmann, JS Rowlinson",,,0,0
Robert Royston Amos (Robin) Coombs. 9,"P Lachmann, H Waldmann",,,0,0
Complement activation by schistosoma mansoni,"F Santoro, A Capron, PJ Lachmann",,,0,0
Evolution and Darwinian Medicine,P Lachmann,,,0,0
REFERENCE EDITION Volume 11,"JF Bach, MD Cooper, K James, CA Janeway Jr, P Lachmann, F Melchers, ...",,,0,0
immunology toduv,"FH Bach, JF Bach, CS Henney, K James, CA JanewayJr, DH Katz, ...",,,0,0
"Abramson, MB, see Choi, M.-u.(540) 337 Andreasen, PA Conversions of the glucocorticoid-recep-tor complex of rat thymocyte cytosol, studied by partition in an aqueous","R Barengo, CR Krisman, J Baron, HA Redick, GF Kapke, LS van Orden III, ...","system 540, 484",,0,0
toda,"JF Bach, MD Cooper, K James, CA Janeway Jr, P Lachmann, F Melchers, ...",,,0,0
Vaccines–current status and future needs,"P Lachmann, J Banatvala, J Blackwell, G Griffin, A Hill, T Lehner, ...",,,0,0
Assistant Editors 4DICAL CETEt,"JR ANDERSON, SG ANDERSON, GL ASHERSON, B ASKONAS, ...",,,0,0
"Mechanisms of cell-mediated cytotoxicity towards muscles infected cells, studies in noral subjects and in multiple sclerosis","P Ewan, P Woo, PJ Lachmann","Menarini Immunopathology Symposium 254, 269-269",,0,0
MW STEWARD,"GGB KLAUS, PJ LACHMANN, RGQ LESLIE, NR LING",,,0,0
IMMUNOLOGYj~ T Tvi r An Official Journal of the British Society for Immunology Vol. 19 No. 6 December 1970,"PJ LACHMANN, AB KAY, RA THOMPSON",,,0,0
EJ HOLBOROW,"JR ANDERSON, SG ANDERSON, GL ASHERSON, BA ASKONAS, ...",,,0,0
